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Summary
The Wingless (Wg)/Wnt signalling pathway controls fundamental processes during animal
development. Deregulation of the Wg/Wnt pathway has been causally linked to several
different forms of cancer, most notably to colorectal cancer. The key effector protein of the
Wg/Wnt pathway is !-catenin which in the absence of the Wnt signal is bound and
phosphorylated by its destruction complex consisting of Adenomatous Polyposis Coli (APC),
Axin, GSK-3!  and Casein Kinase I" . Phosphorylated ! -catenin is then marked for
ubiquitination leading to proteasomal degradation. In the presence of the Wnt ligand, !-
catenin is stabilized and can interact with transcription factors of the Lef/TCF family. !-catenin
can further bind with CBP/p300, Brg-1 and Parafibromin, proteins that have been implicated
in transcription. Originally, !-catenin was discovered for its role in cell adhesion. As part of the
adherens junctions !-catenin binds with "-catenin and E-cadherin. Loss of adherens junctions
has been linked with tumor metastasis.
Several years ago our lab identified two new proteins of the Wg/Wnt signalling
cascade; they were named Legless (Lgs) and Pygopus (Pygo). On the basis of in vivo and
biochemical experiments a model was proposed for nuclear Wg/Wnt signalling. In this model
!-catenin binds Lef/TCF and the adapter protein Lgs which in turn recruits Pygo. In this
quaternary complex Pygo would serve as a transcriptional activator. When I joined the lab we
wanted to investigate if the Lgs-!-catenin interaction could be a valid target for therapeutic
intervention in !-catenin dependent cancers. By using the yeast two-hybrid system I found
that the !-catenin interaction with Lgs critically depends on two amino acids namely, D162
and D164. These acidic amino acids are specifically required for Lgs binding but not for TCF,
E-cadherin or APC binding. I further showed that the Lgs interaction to both endogenous as
well as constitutively active Armadillo (Arm, fly homolog of !-catenin) is necessary for Wg
signalling activity in vivo in Drosophila. In a mammalian tissue culture system, Wnt signalling
also depended on Lgs binding to ! -catenin. These results suggest that Lgs-!-catenin
interaction site can be disrupted specifically without interfering with the binding of !-catenin to
the known tumor suppressor genes APC and E-cadherin. Disrupting the Lgs-!-catenin
interaction has severe consequences for Wg/Wnt signalling but does not affect the adherens
junctions and hence is an attractive drug target for therapeutic intervention.
Thus far we considered Lgs and Pygo as transcriptional coactivators of the pathway.
This view was challenged by the publication of a model where Lgs and Pygo function as a
nuclear anchor for !-catenin (Townsley et al., 2004). Together with Reto Städeli, another PhD
student in the lab, we devised three different experiments in order to distinguish between the
two models. In the first experiment we looked at the signalling and localization of
constitutively active Arm/!-catenin in vivo in Drosophila and in mammalian tissue culture
cells. We compared constitutively active Arm/!-catenin wildtype (wt) with a mutant (D164A)
for Lgs binding. Both forms show a similar localization, but D164A has a severely reduced
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signalling output compared to wt. In the second experiment I tested if one can bypass the
need for Pygo. If the main function of Lgs would be to link !-catenin to the constitutively
nuclear 'anchor' Pygo then Lgs with a nuclear localization signal should function
independently of Pygo. However, constitutively nuclear Lgs still depended on Pygo binding for
its function. In the third experiment Reto introduced a single amino acid substitution in Pygo.
Although this mutant shows the same localization, expression level and binding strength to
Lgs as wt Pygo, it resulted in severely reduced transcription of a Wg target gene. The results
of these experiments argue strongly for a function of Lgs and Pygo as essential
transcriptional coactivators to Arm/!-catenin.
In mammals there are two orthologs of Lgs, namely BCL9 and BCL9.2. The former
was cloned in our lab after the discovery of Lgs in Drosophila. The latter was cloned recently
by two groups (Adachi et al., 2004; Brembeck et al., 2004). One of them reported that BCL9.2
binding to !-catenin depends on tyrosine 142 of !-catenin (Brembeck et al., 2004). Since I
identified the amino acids D162 and D164 of !-catenin to be essential for BCL9 and Lgs
binding, I wanted to test if a Y142A mutant had a similar effect on BCL9 binding and if a
D164A mutant could still bind BCL9.2. In a yeast two-hybrid assay, I found that the !-catenin-
Y142 is essential for "-catenin binding but surprisingly not for BCL9.2 (nor BCL9) binding.
However, BCL9.2 was also dependent on D164 for binding to !-catenin. Y142 is not
necessary in both endogenous as well as constitutively active Arm for Wg signalling activity in
Drosophila. In a mammalian tissue culture system, !-catenin signalling activity also did not
depend on Y142. Furthermore it was reported that BCL9.2 transcriptional activation function
does not depend of Pygo binding (Adachi et al., 2004; Brembeck et al., 2004). I demonstrated
that BCL9.2 can functionally replace Lgs both in tissue culture and in vivo in Drosophila and is
dependent on Pygo binding.
One of the most important questions that still needs further clarification is the function
of Lgs and Pygo in Wnt signalling in vertebrates. I received from the Aguet lab (ISREC,
Lausanne) Pygo double knock-out (KO) mouse embryonic fibroblasts (MEFs). Preliminary
results from signalling assays show that the KO MEFs have lower !-catenin signalling activity
then wt MEFs. The lower activity is caused by the lack of Pygo since adding Pygo to KO
MEFs results in higher signalling activity.
Lgs binds !-catenin at a spatially different location then the proteins CBP/p300, Brg-1
and Parafibromin. The latter three bind !-catenin at the C-terminal half of the protein whereas
Lgs binds more N-terminally. All these proteins have been implicated as transcriptional
coactivators of !-catenin. In my most recent project I'm trying to decipher what the
contributions are of Lgs binding versus binding of the other activators to !-catenin on Wnt
signalling output. For this I compared activity of the D164A mutant with a mutant that has a
deleted C-terminus (!C), which most likely is compromised in binding of CBP/p300 and
Parafibromin. In Drosophila tissue culture cells and in vivo, the C-terminus contributes less
than Lgs binding to signalling. However, in mammalian tissue culture cells the C-terminus is
more important then Lgs binding for activity. The next step is to investigate the functional
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importance of the D164A mutant versus the !C mutant in a vertebrate model organism.
Therefore we started the generation of embryonic stem cells where the endogenous !-catenin
gene is replaced by a mutant one. In total, three different knock-in cell and mouse lines will be
created containing either !-catenin-D164A, !-catenin-!C or !-catenin-D164A-!C. The
characterization of these cell lines and mice will represent an important step forward in the
understanding of nuclear Wnt signalling.
Zusammenfassung 7
Zusammenfassung
Der Wingless (Wg)/Wnt Signalweg kontrolliert grundlegende Abläufe während der
Tierentwicklung. Deregulierung der Wg/Wnt Transduktion wird mit verschiedenen Formen
von Krebs in Verbindung gebracht, am beachtenswertesten davon ist der Dickdarmkrebs.
Das Schlüsselprotein der Wg/Wnt Signalkette ist !-catenin, welches in Abwesenheit des Wnt
Signals gebunden und phosphoryliert wird durch den Zerstörungskomplex, zusammengesetzt
aus den Proteinen Adenomatous Polyposis Coli (APC), Axin, GSK-3! und Casein Kinase I".
Phosphoryliertes !-catenin wird dann markiert für Ubiquitinierung und proteolytischen Abbau.
In der Anwesenheit des Wnt Signals wird ! -catenin stabilisiert und kann mit
Transkriptionsfaktoren der Lef/TCF Proteinfamilie binden. !-catenin kann ebenfalls binden mit
CBP/p300, Brg-1 und Parafibromin. Diese Proteine sind alle beteiligt and der Transkription.
Ursprünglich wurde !-catenin entdeckt durch seine Rolle in der Zell-Zell-Adhäsion. Als Teil
der Adherens Junctions bindet !-catenin mit "-catenin und E-cadherin. Verlust von Zell-Zell-
Kontakten kann Ursache für Metastasenbildung sein.
Vor einigen Jahren hat unser Labor zwei neue Proteine der Wg/Wnt Signalkette
identifiziert und nannte diese Legless (Lgs) und Pygopus (Pygo). Durch in vivo und
biochemische Experimente wurde ein Modell vorgeschlagen für Wg/Wnt Signaltransduktion
im Zellkern. In diesem Modell bindet !-catenin mit Lef/TCF und mit dem Adaptorprotein Lgs,
welches Pygo bindet. In diesem Komplex würde Pygo in der Transkriptionsaktivierung
funktionieren. Zu Beginn meiner Arbeit wollten wir untersuchen, ob die Lgs-!-catenin-
Interaktion ein mögliches Ziel wäre, um !-catenin-abhängigen Krebs therapeutisch zu
bekämpfen. Durch den Gebrauch eines Yeast two-hybrid Systems fand ich, dass die !-
catenin-Bindung zu Lgs abhängig ist von zwei Aminosäuren, D162 und D164. Diese
Aminosäuren sind notwendig für die Lgs-Bindung, aber nicht für die TCF-, E-cadherin- oder
APC-Bindung. Die Lgs-Interaktion mit Armadillo (Arm, Drosohila Homolog von !-catenin) ist
extrem wichtig für die Wg Signalweg in vivo in Drosophila. Auch in einem Säugetier-
Zellkultur-System ist die Lgs-Bindung zu !-catenin wichtig für die Wnt Signalkette. Die
Resultate weisen darauf hin, dass die Lgs-Bindung zu !-catenin spezifisch unterbunden
werden kann, ohne die Interaktion von !-catenin zu den Tumorsuppressor-Proteinen APC
und E-cadherin zu stören. Die Zerstörung der Lgs-!-catenin-Bindung hat grosse Folgen für
den Wg/Wnt Signalweg, aber nicht für Zell-Zell-Kontakte und deshalb ist diese Interaktion
medizinisch höchst interessant.
Bisher sahen wir Lgs und Pygo als transkriptions-aktivierende Moleküle der Wg/Wnt
Signalkette. Diese Sichtweise wurde herausgefordert durch eine Publikation, in deren Modell
Lgs und Pygo als nukleäre Anker für b-catenin funktionieren (Townsley et al., 2004).
Zusammen mit Reto Städeli, einem anderen PhD Studenten im Labor, habe ich drei
Experimente entworfen, um zwischen diesen zwei Modellen unterscheiden zu können. Im
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ersten Experiment haben wir die Signalstärke und die Lokalisierung von aktiviertem Arm/!-
catenin in vivo in Drosophila und in einem Säugetier-Zellkultur-System beobachtet. Wir haben
aktiviertes wildtyp Arm/!-catenin (wt) verglichen mit der mutanten Form (D164A), welche Lgs
nicht binden kann. Beide Formen zeigten die gleiche Lokalisation, aber D164A hatte einen
stark reduzierten Signal-Output im Vergleich zum wt. Im zweiten Experiment habe ich
getestet, ob die Signalkette ohne Pygo funktioniert. Wenn es die Hauptfunktion von Lgs wäre,
!-catenin mit dem nukleären Anker Pygo zu verbinden, dann sollte Lgs mit einem Kern-
Lokalisations-Signal (NLS-Lgs) unabhängig von Pygo sein. Ein konstitutiv nukleäres Lgs
(NLS-Lgs) ist jedoch noch immer abhängig von Pygo für seine Funktion. Im dritten
Experiment hat Reto eine einzige Aminosäure in Pygo ersetzt. Obwohl diese Mutante im
Vergleich zu Pygo wt die nahezu gleiche Lokalisation und Expression aufweist und gleich
stark an Lgs bindet, zeigt die Mutante stark reduzierte Transkriptionsaktivierung eines Wg
Zielgens. Die Resultate dieser Experimente weisen stark auf eine Funktion von Lgs und Pygo
als transkriptionsaktivierende Moleküle für Arm/!-catenin hin.
In Säugetieren gibt es zwei Orthologe von Lgs, nämlich BCL9 und BCL9.2. BCL9
wurde in unserem Labor kloniert, nach der Identifizierung von Lgs in Drosophila. BCL9.2
wurde von zwei verschiedenen Gruppen (Adachi et al., 2004; Brembeck et al., 2004) kloniert.
Eine berichtete, dass die BCL9.2-Bindung zu !-catenin abhängig ist von Tyrosine 142 in !-
catenin (Brembeck et al., 2004). In meinen Experimenten waren die Aminosäuren D162 und
D164 in !-catenin erforderlich für die BCL9- und Lgs-Bindung. Deshalb wollte ich testen, ob
eine Y142A-Mutation in Arm denselben Effekt auf die BCL9-Bindung habe und ob eine
D164A-mutante Form von Arm noch immer BCL9.2 binden könne. Ein Yeast two-hybrid-
Experiment zeigte, dass !-catenin-Y142 notwendig ist für die "-catenin-Bindung, aber
überraschenderweise nicht für die BCL9.2- und BCL9-Bindung. BCL9.2 ist jedoch abhängig
von D164 für seine Bindung zu !-catenin. Arm-Y142 ist nicht wichtig für den Wg Signalweg in
vivo in Drosophila. Auch in einem Säugetier-Zellkultur-System ist der !-catenin Signal-Output
nicht abhängig von Y142. Ausserdem sollte die Transkriptionsaktivierungs-Funktion von
BCL9.2 nicht von der Interaktion mit Pygo abhängen (Adachi et al., 2004; Brembeck et al.,
2004). Ich konnte jedoch in Zellkultur und in vivo in Drosophila zeigen, dass BCL9.2 das
funktionelle Homolog von Lgs ist und dass dessen Funktion ebenfalls abhängt von der
Interaktion mit Pygo.
Eine der wichtigsten Fragen, die noch aufgeklärt werden muss, ist die Funktion von
Lgs und Pygo in der Wnt Signalkette in Wirbeltieren. Vom Aguet Labor (ISREC, Lausanne)
habe ich pygo-doppel-knock-out (KO) embryonale Mausfibroblasten (MEFs) bekommen. Die
ersten Resultate von Signal Output Experimenten zeigten, dass die KO MEFs niedrigere !-
catenin Transkriptionsaktivierung hatten als wt MEFs. Die gesenkte Aktivität wurde
verursacht durch die Abwesenheit von Pygo. Zugabe von Pygo zu den KO MEFs führt zu
einer höheren Aktivität.
Lgs bindet !-catenin an einem anderen Ort als die Proteine CBP/p300, Brg-1 und
Parafibromin, welche !-catenin am C-terminalen Teil binden. Lgs bindet am N-terminalen
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Teil. Jedes von diesen Molekülen ist beteiligt an der Transkriptionsaktivierung von !-catenin.
In meinem letzten Projekt versuche ich herauszufinden, was der Anteil der Lgs-Bindung
verglichen mit der Bindung der anderen Moleküle zu !-catenin für die Wnt Signalkette ist.
Deshalb vergleiche ich die Aktivität der D164A-Mutanten mit einer Mutante, welcher der C-
terminus fehlt (!C). Diese Mutante kann höchst wahrscheinlich CBP/p300 und Parafibromin
nicht binden. In Drosophila (Zellkultur und in vivo) trägt der C-terminus von Arm weniger zur
Wg Signalkette bei als die Lgs-Bindung. In einer Säugetier-Zellkultur hingegen trägt der C-
terminus mehr bei als die Lgs-Bindung. Der nächste Schritt ist die Untersuchung des Anteils
einer Lgs-Bindemutante von !-catenin verglichen mit einer C-terminalen Deletion (!C) in
einem Wirbeltier Modellorganismus. Deshalb haben wir mit der Herstellung von embryonalen
Stammzellen begonnen, in welchen das endogene !-catenin-Gen ersetzt wird durch ein
mutantes. Insgesamt werden drei verschiedene knock-in Zell- und Maus-Linien erzeugt mit !-
catenin-D164A, !-catenin-!C oder !-catenin-D164A-!C. Die Charakterisierung dieser
Zelllinien und Mäuse wird ein grosser Schritt sein hin zum besseren Verständnis des Wnt
Signalweges im Zellkern.
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1. Introduction
1.1 Transcription under nuclear Arm's control
Reto Städeli
1
, Raymond Hoffmans
1
 and Konrad Basler
Accepted in Current Biology
1
 These authors contributed equally to this work and should be considered co-first
authors.
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Abstract
The Wingless/Wnt pathway controls cell fates during animal development and
regulates tissue homeostasis as well as stem cell number and differentiation in
epithelia. Deregulation of Wnt signaling has been associated with cancer in humans. In
the nucleus, the Wingless/Wnt signal is transmitted via the key effector protein
Armadillo/!-catenin. The recent identification and functional analysis of novel
Armadillo/!-catenin interaction partners provide new and exciting insights into the
highly complex mechanism of Wingless/Wnt target gene activation.
Signaling molecules of the Wingless (Wg)/Wnt family are secreted glycoproteins that control a
diverse array of processes in both embryos and adults. The Wnt cascade has been
implicated in the postembryonic regulation of stem cell number and differentiation of several
adult stem cell systems (reviewed in [1, 2]). Moreover, the pathway has been causally linked
to various diseases, most notably to cancer (reviewed in [3, 4]). In the absence of the Wg/Wnt
signal, DNA-bound transcription factors of the T-cell factor (TCF) family of HMG-box proteins
bind the transcriptional repressor proteins Groucho/TLE and CtBP. Upon activation of the
pathway the key transducing component Armadillo/!-catenin becomes stabilized, enters the
nucleus and heterodimerizes with TCFs to activate the expression of Wg/Wnt target genes.
This co-activator function of Arm/!-catenin depends mainly on two arms: An N-terminal
activating arm (NTAA) recruiting Legless and Pygopus, and a C-terminal activating arm
(CTAA) binding to CBP, Brahma/Brg-1, MED12, and Hyrax/Parafibromin. Despite its
therapeutic relevance, the mechanisms by which Arm/!-catenin employs these co-factors to
control the transcription of target genes is only poorly understood. Here we review past and
recent findings that relate to this problem and discuss how they can be integrated into a more
complete picture of Wg/Wnt target gene activation.
The Armament of the Wg/Wnt Signaling System
Armadillo (Arm)/!-catenin fulfills two main functions in the cell: (i) as a component of the
cadherin-based cell adhesion system it binds the transmembrane protein E-cadherin and
regulates actin filament assembly via "-catenin (reviewed in [5]); and (ii) as a nuclear
regulator of Wingless (Wg)/Wnt dependent gene expression it provides transcriptional
activator functions to TCFs. The Arm/!-catenin protein consists of a central region that is
made up of 12 imperfect armadillo repeats (R1-12) flanked by an N- and a C-terminal tail [6].
There are forms of Arm carrying mutations or deletions which interfere with the adhesion
function, but not with its role in Wg/Wnt signaling, and vice versa, indicating that these two
functions of Arm are independent and separable [7, 8]. Interestingly, the small nematode C.
elegans has three different !-catenin proteins which possess separate functions dedicated
either to adhesion (HMP-2) or to Wnt signaling (WRM-1 and BAR-1) [9]. In the absence of the
Wg/Wnt signal, cytosolic Arm/!-catenin is constantly phosphorylated by the action of a so-
called ‘degradation complex’ consisting of the Adenomatous polyposis coli (APC) protein,
1. Introduction 12
Axin, and the kinases casein kinase I (CKI) and Shaggy/Zeste white-3 (GSK-3!) and hence
rapidly degraded via the ubiquitin/proteasome pathway (reviewed in [10]). Interaction of the
Wg/Wnt ligand with its receptors Frizzled and Arrow/LRP (LDL-receptor-related protein)
blocks the degradation complex and leads to the stabilization of Arm/!-catenin. Such Arm/!-
catenin protein accumulates in the cytoplasm and can enter the nucleus, where it acts as a
co-activator of TCFs [11-16] (Figure 1). Artificially preventing Arm from entering the nucleus
blocks Wnt signaling [17], while forcing it into the nucleus can have the opposite effect [18-
20]. Therefore, the signaling activity of Arm/!-catenin is largely controlled by the size of its
nuclear pool, which depends on the cytoplasmic levels of !-catenin as well as on the import
into and export out of the nucleus.
Arm’s Import and Export
The business of Arm’s import and export is rather nebulous and somewhat controversial.
Below we summarize what has been reported. !-catenin appears to be imported into the
nucleus in a NLS- and importin/karyopherin-independent manner by directly interacting with
nuclear pore components [21, 22]. Addition of cytosol inhibited nuclear import of !-catenin
[21, 22], indicative of the presence of cytosolic retention factors. Indeed, it was shown that
Figure 1: Simplified overview of the Wg/Wnt signaling pathway
The cell to the left shows the OFF state of the Wg/Wnt pathway. In the absence of the Wnt signal, Armadillo
(Arm)/!-catenin protein levels are downregulated by a complex containing Adenomatous polyposis coli
(APC) protein, Axin, casein kinase I (CKI), and glycogen synthase kinase-3 (GSK-3!). In addition, the co-
repressors Groucho (Gro)/TLE and C-terminal binding protein (CtBP) are bound to T-cell factor (TCF). The
cell to the right represents the ON state of the pathway. The Wg/Wnt ligand binds Frizzled and its co-
receptor Arrow/LRP (LDL-receptor-related protein). Axin is bound by Dishevelled (Dvl) and Arrow, thereby
disrupting the 'degradation complex'. Arm/!-catenin accumulates in the cytoplasm, enters the nucleus and
displaces Gro from TCF. For transcription of target genes Arm/!-catenin interacts with Legless (Lgs), which
binds Pygopus (Pygo), and with C-terminal activating arm binding proteins (CTAA-BPs) such as CREB-
binding protein (CBP)/p300, Hyrax/Parafibromin, TATA Binding Protein (TBP), MED12, and Brahma/Brg-1
(Brahma-related gene-1). As part of adherens junctions, Arm binds the transmembrane protein E-cadherin
(E-cad) and the cytoplasmic protein "-catenin ("). Negatively acting components of the pathway are
colored in red with white letters, while positive components are shown in green with black letters.
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Axin could play such a role in Drosophila [23]. Pangolin (Pan, dTCF), on the other hand, can
function to keep Arm in the nucleus [23]. However, a mutant form of Arm, that is defective in
binding Pan, still localizes to the nucleus [7, 15]. It has also been proposed that Legless (Lgs)
in cooperation with Pygopus (Pygo) serves as a nuclear anchor for Arm [20]. However, Arm
still localizes to the nucleus in axin pygo double-mutant clones, suggesting that Pygo acts
downstream of Arm nuclear localization [24, 25]. These findings show the difficulty in
designing experiments to clearly separate the process of nuclear import and retention of
Arm/!-catenin. While the region comprising R10-C seems to be necessary and sufficient for
the nuclear import [26], different regions of Arm/!-catenin that interact with binding partners
such as the above mentioned dTCF and Lgs (together with Pygo) could serve as anchor
points contributing to nuclear retention of Arm/!-catenin. To further increase complexity, Arm
also has an intrinsic nuclear export activity [21, 22, 27], which has been mapped and shown
to overlap with its ‘import region’ [26]. Furthermore, Axin [28] and APC [29-31] may facilitate
nuclear export of Arm. However, a recent paper that investigated the nucleo-cytoplasmic
shuttling of !-catenin and its relation to TCF4, BCL9 (B-cell lymphoma 9, Lgs homolog in
mammals), APC, and Axin [32] demonstrated that these proteins do not accelerate the
Figure 2: Nucleo-cytoplasmic shuttling of Arm/!-catenin
Left side: Nuclear import of Arm works independently of the carrier proteins Importin (Imp) "/! and is
mediated by direct interaction of Arm with components of the nuclear pore complex (NPC). Arm’s release
into the nucleus does not depend on RanGTP. Nuclear import of Arm can be counteracted by cytosolic
retention factors such as Axin and E-cadherin.
Right side: Nuclear export of Arm works in an Exportin-/RanGTP-independent manner, and no Ran GTPase
activating protein (RanGAP) is required to release Arm on the cytosolic side. Proteins like APC and Axin,
which can bind Arm and shuttle between the nucleus and the cytoplasm (Ran dependent), may facilitate
nuclear export of Arm, whereas nuclear proteins that interact with Arm, like TCFs or Legless (together with
Pygopus), might serve as nuclear retention factors and decrease the nuclear export rate of Arm.
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import/export rate of !-catenin. They rather act in retaining !-catenin in the compartment in
which they are localized. In summary, the intracellular localization of Arm/!-catenin
represents a dynamic equilibrium of its intrinsic nuclear import and export activities as well as
the availability and affinity of its binding partners (Figure 2).
Harm by nuclear Arm: Breaking the ‘non-proliferation treaty’
Mutations that constitutively stabilize Arm/!-catenin can cause colorectal carcinomas and
other forms of cancer. One recent view described such cancers as a ‘stem cell disease’ [33].
All cells in a normal colonic crypt are thought to be derived from epithelial stem cells located
to the bottom of each crypt and maintained as stem cells by a Wnt signaling system [34].
Aberrant activation of the Wnt pathway leads to an expansion of this stem cell population into
upper regions of the crypt. Instead of differentiating such cells assume stem cell-like
replication properties, causing overproliferation and the accumulation of mutations, finally
resulting in polyps and adenomatous lesions in the colon (Figure 3) (reviewed in [33, 35]).
The best-studied example, Familial Adenomatous Polyposis (FAP), is in most cases caused
by truncations in APC [36, 37]. Truncated APC can no longer fulfill its function in Arm/!-
catenin degradation. As a consequence, Arm/!-catenin accumulates and enters the nucleus
where it activates target genes implicated in cell proliferation (e.g. c-Myc [38] and gastrin
[39]), inhibition of apoptosis (e.g. survivin [40]), and tumor progression (e.g. Laminin #2 [41])
(Figure 3). The molecular basis of how such target genes exert their harmful effect in the
various steps towards tumorigenesis is currently not well understood and will not be
discussed further. However, especially the Arm/!-catenin targets implicated in cell
proliferation would fit into the view of cancer as a ‘stem cell disease’. How are these nuclear
Arm/!-catenin targets activated?
Nuclear Arm races towards TCF and displaces Groucho/TLE
In the absence of nuclear Arm/!-catenin, Pan/TCF is bound to Groucho/TLE [42, 43] and
CtBP (C-terminal binding protein) [44-47]. Groucho/TLE family proteins are general long-
range transcriptional co-repressors, which have been shown to interact with histone
deacetylases (HDAC) [48]. Reduction of Pan or Groucho in the Drosophila embryo results in
partial suppression of armadillo and wingless mutant phenotypes, whereas overexpression of
Pan enhances the phenotype of a weak wingless allele [43]. This suggests that, in the
absence of Wg signaling, a Pan-Groucho complex acts as a repressor of Wg targets in the
embryo. In contrast, loss of Pan in the Drosophila wing imaginal disc results in a reduction of
Wg target gene expression, but does not cause a derepression of these genes outside the
normal domain of expression. Loss of Groucho also does not result in derepression of Wg
target genes [49]. Thus, Pangolin does not appear to function by default as a repressor in the
wing imaginal disc in the absence of Wg signaling. Rather it seems that the repressor function
of Pan can vary in different tissues. Nuclear Arm/!-catenin binds to the N-terminus of
Pan/TCF and displaces Groucho/TLE by binding to a second, low-affinity binding site on TCF
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located in the C-terminal half of the protein, which overlaps with the Groucho/TLE binding site
[50]. Interestingly, neither the N- nor the C-terminus of !-catenin are necessary for this
displacement, suggesting that it is – like TCF binding – accomplished by the central Arm
repeat domain. CtBP proteins are general short-range transcriptional co-repressors that
interact with HDACs (reviewed in [51]). TCF3 and TCF4 have been shown to bind CtBP in
vitro and in vivo [44-47]. The binding of CtBP represses TCF3- and TCF4-mediated
transcription [44-46] and this repression depends on HDAC activity [44]. To date it is not clear
how Wnt signaling overcomes the repressor effect of CtBP on TCF3 and TCF4 and whether
!-catenin plays an active role in this process.
After the release of the Grouche/TLE and CtBP repressor systems from Pan/TCF,
nuclear Arm/!-catenin can fully develop its transcriptional activator potential.
Arm's Activating Arms
In the nucleus, Arm/!-catenin binds the DNA binding protein Pan/TCF/LEF through R3-10
[11-16, 52] (Figure 4). In addition to the Pan/TCF/LEF binding domain, there are two other
domains which are important for Wg/Wnt signaling, namely R1 and R11-C [7]. It was shown
recently that R1-4 are necessary and sufficient for Lgs binding [8, 53-55], and that R11-C are
important for the binding of proteins such as CBP (CREB-binding protein )/p300,
Hyrax/Parafibromin, TBP (TATA Binding Protein), MED12, and Brahma/Brg-1 (Brahma-
related gene-1) [56-61]. Mutations in or deletions of these two domains result in Arm/!-
catenin proteins with reduced signaling activity [7, 8, 15, 62, 63]. On the other hand, both
domains have been shown to exhibit signaling activity on their own [15, 18, 54]. From here on
Figure 3: Model for colorectal cancer (CRC)
The left side of the crypt is wild type. A Wnt signal at the bottom of the crypt blocks !-catenin degradation,
thereby activating target genes that maintain cell proliferation (green cells). Halfway up the crypts, !-catenin
is downregulated and the progenitor crypt cells start to differentiate (blue cells). The right side of the crypt
shows cells that have a mutation in either APC or !-catenin (red cells), which results in a constitutive
activation of the target genes and prevents such cells from differentiating. The cells maintain their
progenitor state and continuously proliferate. Adapted from [90].
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we refer to these two activating arms of Arm/!-catenin as 'NTAA' and 'CTAA' for N-terminal
activating arm (R1-5) and C-terminal activating arm (R10-C), respectively.
An armada of nuclear Arm auxiliary factors
CTAA collaborators
!-catenin has several partners that bind the CTAA and contribute to transcriptional activation,
five of which are briefly discussed here. (i) One of these proteins is TBP, which has been
shown to bind !-catenin at R12-C [57]. Noteworthy, there are two more domains in !-catenin
that bind TBP, namely the N-terminus and R2-4. So far, solid experimental data for the
functional significance of the !-catenin–TBP interaction is lacking. (ii) Brg-1, a component of
mammalian SWI/SNF and Rsc chromatin remodeling complexes, has been shown to bind
Arm/!-catenin through R7-12. Overexpression of Brg-1 promotes transcriptional activation of
TCF-responsive reporter genes. In Drosophila, Brahma genetically interacts with Arm [56]. (iii)
p300 and the closely related CBP are co-activators that link proteins to the basal transcription
machinery or alter chromatin structure through their intrinsic or associated histone
acetyltransferase (HAT) activities. p300 and CBP bind R10-C of !-catenin and stimulate
transcriptional activity [58, 59]. Interestingly, although the co-activators p300 and CBP are
closely related, they do not always exert the same effects on promoters; for instance, they
have opposite effects on the !-catenin-mediated expression of the survivin gene. The small
molecule ICG-001, which specifically blocks the CBP-!-catenin interaction, but not the p300-
!-catenin interaction, inhibits survivin gene expression. In the absence of ICG-001, CBP is
associated with the survivin promoter. In the presence of ICG-001 there is less CBP at the
promoter but more p300 instead, which in turn recruits repressive elements and results in a
reduction of survivin transcription [64]. (iv) Recently, it has been shown that the human and
Drosophila homologs of yeast Cdc73p (Parafibromin and Hyrax, respectively) are involved in
Wg/Wnt signaling. Cdc73p is a component of the PAF1 complex, a conserved RNA
Figure 4: Schematic overview of what binds where on Arm/!-catenin
The Arm repeats are numbered 1–12. Blue lines show the N-terminal activating arm (NTAA) and the C-
terminal activating arm (CTAA). The black lines represent binding domains of Arm/!-catenin interacting
proteins. APC (Adenomatous polyposis coli), " ("-catenin), TCF (T-cell factor), Lgs (Legless), CBP (CREB-
binding protein, CREB (cAMP response-element binding protein)), Brg-1 (Brahma-related gene-1), TBP
(TATA binding protein), MED12 (Mediator subunit 12).
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polymerase II interacting complex, which has been implicated in the regulation of
transcriptional initiation and elongation (reviewed in [65]). Hyrax and Parafibromin bind to
R12-C of Arm and !-catenin, respectively. Overexpression of these proteins results in an
increase of Wg/Wnt pathway activity, while experimental reduction of their levels has the
opposite effect [60]. (v) MED12, a component of the Mediator complex, has been found to
interact with !-catenin R12-C [61]. The Mediator (MED) complex, first discovered in yeast,
links transcriptional regulators to RNA polymerase II (Pol II) and general transcription factors
[66-68]. Meanwhile, counterparts for nearly all yeast MED components have been discovered
in mammals (reviewed in [69-71]). Both RNAi-mediated knock-down of MED12 as well as
overexpression of the isolated !-catenin binding domain of MED12 in HeLa cells impaires !-
catenin-dependent transactivation in response to Wnt signaling [61].
Beside the five co-activator partners, described above, that bind directly to the CTAA
of !-catenin, it was recently shown that the TRRAP/TIP60, the ISW1, and the MLL1/MLL2
SET1-type complexes also selectively associate with the CTAA [72]. All three of these
complexes are involved in histone modification and chromatin remodeling. It has not been
resolved yet whether these complexes interact directly with !-catenin.
NTAA collaborators
Pontin/Tip49 and Reptin/Tip48 are two highly homologous proteins, which can form homo-
and heterodimers. They have been shown to bind to !-catenin R2-5 and antagonistically
affect !-catenin output. Reptin inhibits and Pontin enhances transcriptional activation of
reporter genes. In Drosophila, mutations in the pontin and reptin genes exhibited opposite
dominant effects on wing phenotypes in a genetic background sensitized for Arm signaling
[73, 74]. Also in zebrafish Pontin and Reptin function antagonistically: the liebeskummer (lik)
mutation encodes an activated Reptin protein, which promotes cardiac hyperplasia. This
phenotype was enhanced by reduction of !-catenin or pontin expression in a heterozygous lik
mutant [75]. In a chromatin immunoprecipitation experiment Pontin, Tip60, and TRRAP
interacted with the promoter of a TCF-dependent gene, ITF-2 (immunoglobulin transcription
factor-2). Overexpression of a mutant inactive form of Pontin resulted in decreased
acetylation of histones and reduction of ITF-2 expression [76]. The domains of !-catenin, to
which Pontin, Reptin and Lgs bind, are overlapping (R2-5 and R1-4). However, it is presently
unknown whether they bind simultaneously or in a competitive manner.
Lgs and Pygo were discovered in genetic screens for modifiers of the Drosophila Wg
pathway [24, 25, 53, 77]. Loss of lgs or pygo function results in a severe reduction of pathway
output. Arm/!-catenin binds Lgs through R1-4 and the acidic amino acids D162 and D164
play a key role in this protein-protein interaction [8, 53]. Replacing wild-type Arm with Arm-
D164A (which cannot bind Lgs) causes phenotypes that are very similar to those of lgs null
mutants [8]. The predominantly nuclear localization of Lgs depends on the presence of Pygo
[20]. It has been proposed that Lgs and Pygo function mainly to enhance the nuclear levels of
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Arm [20, 78]. This notion was based on an experiment in which the cuticular phenotype of lgs
and pygo mutant embryos was ameliorated by overexpressing a form of Arm with a nuclear
localization signal. This experiment indeed showed that high amounts of nuclear Arm can
activate dTCF targets in the absence of Lgs or Pygo, most likely by displacing Groucho/TLE
from Pan and by recruiting the above-described activators via the CTAA. However, in a
different set of experiments it was shown that a DNA-tethered and constitutively nuclear form
of !-catenin can only very poorly activate reporter gene expression if it carries the D164A
mutation, suggesting that BCL9 binding critically contributes to !-catenin’s activator capacity
[79]. Furthermore, constitutive nuclear targeting of Lgs does not bypass the requirement for
Pygo in Wg signaling, indicating that Pygo must provide a function beyond ensuring the
availability of Lgs and Arm/!-catenin in the nucleus of Wg-transducing cells [79]. These
findings therefore argue that Arm depends on Lgs and Pygo primarily for its transcriptional
output rather than for its nuclear import or retention. They also argue that in addition to the
Arm/!-catenin CTAA, there is a Lgs-Pygo-dependent output from the NTAA important for Arm
activity. In this NTAA function, Lgs appears to serve as an adaptor protein linking Pygo to
Arm/!-catenin [53] while the N-terminal homology domain of Pygo (PygoNHD) is a critical
mediator of this function, as it cannot be bypassed [54].
How to activate a nuclear Arm…
Transcriptional activation of target genes requires the recruitment of ATP-dependent
chromatin remodeling enzymes and histone acetyltransferase (HAT) complexes to their
promoters to ‘prepare’ the chromatin. There appears to be no obligate order of function for
these complexes (reviewed in [80]). After chromatin preparation, RNA polymerase II is
recruited and transcription initiated. In the case of the LEF-!-catenin complex it has been
shown that R11-C of !-catenin is necessary for chromatin remodelling in vitro [81]. This
region of !-catenin partially overlaps with binding sites for Brg-1 (R7-12) and p300/CBP (R10-
C). These two proteins could be involved in the preparation of chromatin at Wg/Wnt target
genes. In addition, components of the MLL/SET1-type chromatin modifying complexes
associate with this domain of !-catenin and augment histone methyl transferase (HMT)
activity and H3K4 trimethylation at the Wnt target gene c-Myc [72].
With the identification of MED12 as a !-catenin binding protein, there is now a link
between !-catenin and Pol II: The MED complex can associate with Pol II to generate a
stable complex sometimes called the Pol II holoenzyme (reviewed in [82, 83]). Yet another
link between !-catenin and Pol II comes forward with the discovery of Hyrax/Parafibromin as
an Arm/!-catenin interaction partner, which interestingly also binds to the CTAA and thus
overlaps with the Brahma/Brg-1, CBP/p300, and MED12 binding sites. The PAF1
(polymerase associated factor) complex, which contains Parafibromin, has been found to
associate with the nonphosphorylated and Ser2 and Ser5 phosphorylated forms of the Pol II
large subunit [84]. Another study describes the tumor suppressor Parafibromin as a PAF1
complex- and Pol II-bound protein acting in transcription elongation and RNA processing [85].
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As the PAF1 complex has been shown to physically interact with the SET1 complex [86], an
attractive idea would describe the role of Hyrax/Parafabromin as a recruiting module not only
for Pol II, but also for the MLL/SET1-type complexes.
Mosimann et al. [60] showed that there might be a Hyrax/Parafibromin-related
crosstalk between the CTAA of !-catenin and Pygo. As described above, overexpression of
Parafibromin leads to an increase in Wnt-reporter gene activity in tissue culture cells.
However, this increase depends on Pygo as it can be abrogated by the siRNA-mediated
reduction of Pygo. In other words, the activating function of Hyrax/Parafibromin in the Wg/Wnt
pathway seems to depend on the recruitment of Pygo to !-catenin. These findings could be
interpreted to implicate Pygo in stabilizing or exchanging trans-activating complexes that bind
the Arm/!-catenin CTAA.
Taken together, a model can be composed (depicted in Figure 5) in which Wg/Wnt
target gene activation might be a concerted, Pygo-assisted process, which dynamically
coordinates the sequential action of transcriptional modulators at the central scaffold protein
Arm/!-catenin.
Figure 5: Model of nuclear Arm’s control over transcription
Nuclear Arm is recruited to Wingless target genes by high mobility group (HMG) transcription factors of the
TCF/LEF family, which all have an Armadillo-binding domain (ABD) at their very N-termini. Arm acts
through two activating arms. (i) The N-terminal activating arm acts mainly through binding Legless (Lgs) at
its homology domain 2 (HD2). Lgs, via its homology domain 1 (HD1), can recruit the co-activator Pygopus
(Pygo) by binding its plant homology domain (PHD). (ii) The C-terminal activating arm can interact with
protein complexes exhibiting histone acetyltransferase (HAT) or chromatin remodeling (SWI/SNF complex)
activities. Other interaction partners are components that can recruit histone methyltransferases (e.g.
MLL/SET1) or play important roles in transcription initiation and elongation (PAF1 complex, MED complex).
Sequential or random recruitment of these factors and complexes, step-by-step, results in a more
accessible chromatin structure and finally leads to transcription of the target gene.
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… and how to disarm it
Although not much is currently known about how Arm/!-catenin-regulated genes are turned
off, three processes are likely to be important: (i) disassembly of the Arm/!-catenin enhancer
complex, (ii) reversion of the 'activating' histone modifications, and (iii) nuclear export and
degradation of Arm/!-catenin. Recent work by Sierra et al. [72] raises the possibility that APC
may be a key protein involved in all three of these processes. The association of full-length
APC with the Wnt-dependent enhancer of the c-Myc gene correlated with the disassembly of
the !-catenin enhancer complex, resulting in a rapid decrease of c-Myc mRNA levels. Sierra
et al. [72] proposed that full-length APC may recruit CtBP and !-TrCP (!-Transducin repeats-
containing protein) to the c-Myc enhancer. APC has previously been shown to directly interact
with CtBP, both in vivo and in vitro [47]. LSD1 (Lysine Specific Demethylase 1), a component
of CtBP complexes, has been implicated in reverting H3K4 mono- and di-methylation in vitro
[87]. To our knowledge, factors that catalyze the removal of a methyl group from tri-
methylated lysines (e.g. H3K4(CH3)3) have not yet been described. APC may further bind to
Arm/!-catenin and remove it from TCF/LEF, which in turn is then free to recruit Groucho/TLE-
1 and HDAC complexes, while APC might facilitate nuclear export of Arm/!-catenin (reviewed
in [88, 89]) and promote its cytosolic degradation.
This scenario, in which a nuclear pool of APC counteracts Wnt signaling at multiple
levels, still lacks definitive experimental confirmation and also raises some unanswered
questions. For example, how is APC recruited to enhancers of TCF/LEF target genes, when
Arm/!-catenin cannot interact simultaneously with TCF/LEF and APC due to overlapping
binding sites? Does APC perhaps interact with other subunits of the Arm/!-catenin enhancer
complex? Undoubtedly however, the mechanism by which APC counteracts transcription of
Wg/Wnt targets will be key to understand how Arm and !-catenin undergo nuclear
disarmament.
The future of nuclear Arms
Lgs and Pygopus have so far mainly been analyzed in Drosophila. While those studies clearly
show that both proteins are very important for Wg signaling, little is known so far about their
significance in the vertebrate pathway. It was shown in zebrafish that B9L (BCL9-like or
BCL9.2) is required for the induction of the T-box transcription factor tbx6, a Wnt8 target gene
[55]. It will be very interesting to see what the phenotypes of mouse lgs and pygo knock-outs
are. Will the NTAA of !-catenin play an equally essential role for Wnt pathway output as the
CTAA? Or are there species-specific differences regarding their requirements? For the CTAA,
future studies will shed more light on the C-terminal interactors. Is their order of action
constant and critical, or can they transcriptionally prepare and activate Wnt targets by variable
means? What about genes repressed by Wnt signaling? Is Arm/!-catenin also able to
function as a Wnt signal-dependent repressor of gene transcription, or are Wnt-repressed
genes only indirectly regulated by nuclear Arm/!-catenin? Clearly, resolving the unclear
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issues of nuclear Arms will necessitate efforts in different fields. The reward may not only be
to understand, but also to interfere with, aberrant pathway activity.
References
1. Radtke, F., and Clevers, H. (2005). Self-renewal and cancer of the gut: two sides of a
coin. Science 307, 1904-1909.
2. Reya, T., and Clevers, H. (2005). Wnt signalling in stem cells and cancer. Nature
434, 843-850.
3. Moon, R.T., Kohn, A.D., De Ferrari, G.V., and Kaykas, A. (2004). WNT and beta-
catenin signalling: diseases and therapies. Nat Rev Genet 5, 691-701.
4. Logan, C.Y., and Nusse, R. (2004). The Wnt signaling pathway in development and
disease. Annu Rev Cell Dev Biol 20, 781-810.
5. Gates, J., and Peifer, M. (2005). Can 1000 reviews be wrong? Actin, alpha-Catenin,
and adherens junctions. Cell 123, 769-772.
6. Huber, A.H., Nelson, W.J., and Weis, W.I. (1997). Three-dimensional structure of the
armadillo repeat region of beta-catenin. Cell 90, 871-882.
7. Orsulic, S., and Peifer, M. (1996). An in vivo structure-function study of armadillo, the
beta-catenin homologue, reveals both separate and overlapping regions of the
protein required for cell adhesion and for wingless signaling. J Cell Biol 134, 1283-
1300.
8. Hoffmans, R., and Basler, K. (2004). Identification and in vivo role of the Armadillo-
Legless interaction. Development 131, 4393-4400.
9. Korswagen, H.C., Herman, M.A., and Clevers, H.C. (2000). Distinct beta-catenins
mediate adhesion and signalling functions in C. elegans. Nature 406, 527-532.
10. Polakis, P. (2002). Casein kinase 1: a Wnt'er of disconnect. Curr Biol 12, R499-R501.
11. Behrens, J., von Kries, J.P., Kuhl, M., Bruhn, L., Wedlich, D., Grosschedl, R., and
Birchmeier, W. (1996). Functional interaction of beta-catenin with the transcription
factor LEF-1. Nature 382, 638-642.
12. Molenaar, M., van de Wetering, M., Oosterwegel, M., Peterson-Maduro, J., Godsave,
S., Korinek, V., Roose, J., Destree, O., and Clevers, H. (1996). XTcf-3 transcription
factor mediates beta-catenin-induced axis formation in Xenopus embryos. Cell 86,
391-399.
13. Huber, O., Korn, R., McLaughlin, J., Ohsugi, M., Herrmann, B.G., and Kemler, R.
(1996). Nuclear localization of beta-catenin by interaction with transcription factor
LEF-1. Mech Dev 59, 3-10.
14. Riese, J., Yu, X., Munnerlyn, A., Eresh, S., Hsu, S.C., Grosschedl, R., and Bienz, M.
(1997). LEF-1, a nuclear factor coordinating signaling inputs from wingless and
decapentaplegic. Cell 88, 777-787.
15. van de Wetering, M., Cavallo, R., Dooijes, D., van Beest, M., van Es, J., Loureiro, J.,
Ypma, A., Hursh, D., Jones, T., Bejsovec, A., Peifer, M., Mortin, M., and Clevers, H.
(1997). Armadillo coactivates transcription driven by the product of the Drosophila
segment polarity gene dTCF. Cell 88, 789-799.
16. Brunner, E., Peter, O., Schweizer, L., and Basler, K. (1997). pangolin encodes a Lef-
1 homologue that acts downstream of Armadillo to transduce the Wingless signal in
Drosophila. Nature 385, 829-833.
17. Cox, R.T., Pai, L.M., Miller, J.R., Orsulic, S., Stein, J., McCormick, C.A., Audeh, Y.,
Wang, W., Moon, R.T., and Peifer, M. (1999). Membrane-tethered Drosophila
Armadillo cannot transduce Wingless signal on its own. Development 126, 1327-
1335.
18. Hsu, S.C., Galceran, J., and Grosschedl, R. (1998). Modulation of transcriptional
regulation by LEF-1 in response to Wnt-1 signaling and association with beta-catenin.
Mol Cell Biol 18, 4807-4818.
19. Miller, J.R., and Moon, R.T. (1997). Analysis of the signaling activities of localization
mutants of beta-catenin during axis specification in Xenopus. J Cell Biol 139, 229-
243.
20. Townsley, F.M., Cliffe, A., and Bienz, M. (2004). Pygopus and Legless target
Armadillo/beta-catenin to the nucleus to enable its transcriptional co-activator
function. Nat Cell Biol 6, 626-633.
1. Introduction 22
21. Yokoya, F., Imamoto, N., Tachibana, T., and Yoneda, Y. (1999). beta-catenin can be
transported into the nucleus in a Ran-unassisted manner. Mol Biol Cell 10, 1119-
1131.
22. Fagotto, F., Gluck, U., and Gumbiner, B.M. (1998). Nuclear localization signal-
independent and importin/karyopherin-independent nuclear import of beta-catenin.
Curr Biol 8, 181-190.
23. Tolwinski, N.S., and Wieschaus, E. (2001). Armadillo nuclear import is regulated by
cytoplasmic anchor Axin and nuclear anchor dTCF/Pan. Development 128, 2107-
2117.
24. Parker, D.S., Jemison, J., and Cadigan, K.M. (2002). Pygopus, a nuclear PHD-finger
protein required for Wingless signaling in Drosophila. Development 129, 2565-2576.
25. Belenkaya, T.Y., Han, C., Standley, H.J., Lin, X., Houston, D.W., and Heasman, J.
(2002). pygopus Encodes a nuclear protein essential for wingless/Wnt signaling.
Development 129, 4089-4101.
26. Koike, M., Kose, S., Furuta, M., Taniguchi, N., Yokoya, F., Yoneda, Y., and Imamoto,
N. (2004). beta-Catenin shows an overlapping sequence requirement but distinct
molecular interactions for its bidirectional passage through nuclear pores. J Biol
Chem 279, 34038-34047.
27. Wiechens, N., and Fagotto, F. (2001). CRM1- and Ran-independent nuclear export of
beta-catenin. Curr Biol 11, 18-27.
28. Cong, F., and Varmus, H. (2004). Nuclear-cytoplasmic shuttling of Axin regulates
subcellular localization of beta-catenin. Proc Natl Acad Sci U S A 101, 2882-2887.
29. Rosin-Arbesfeld, R., Townsley, F., and Bienz, M. (2000). The APC tumour
suppressor has a nuclear export function. Nature 406, 1009-1012.
30. Neufeld, K.L., Zhang, F., Cullen, B.R., and White, R.L. (2000). APC-mediated
downregulation of beta-catenin activity involves nuclear sequestration and nuclear
export. EMBO Rep 1, 519-523.
31. Henderson, B.R. (2000). Nuclear-cytoplasmic shuttling of APC regulates beta-catenin
subcellular localization and turnover. Nat Cell Biol 2, 653-660.
32. Krieghoff, E., Behrens, J., and Mayr, B. (2006). Nucleo-cytoplasmic distribution of
{beta}-catenin is regulated by retention. J Cell Sci 119, 1453-1463.
33. Taipale, J., and Beachy, P.A. (2001). The Hedgehog and Wnt signalling pathways in
cancer. Nature 411, 349-354.
34. Booth, C., and Potten, C.S. (2000). Gut instincts: thoughts on intestinal epithelial
stem cells. J Clin Invest 105, 1493-1499.
35. Bienz, M., and Clevers, H. (2000). Linking colorectal cancer to Wnt signaling. Cell
103, 311-320.
36. Nishisho, I., Nakamura, Y., Miyoshi, Y., Miki, Y., Ando, H., Horii, A., Koyama, K.,
Utsunomiya, J., Baba, S., and Hedge, P. (1991). Mutations of chromosome 5q21
genes in FAP and colorectal cancer patients. Science 253, 665-669.
37. Kinzler, K.W., Nilbert, M.C., Su, L.K., Vogelstein, B., Bryan, T.M., Levy, D.B., Smith,
K.J., Preisinger, A.C., Hedge, P., McKechnie, D., and et al. (1991). Identification of
FAP locus genes from chromosome 5q21. Science 253, 661-665.
38. He, T.C., Sparks, A.B., Rago, C., Hermeking, H., Zawel, L., da Costa, L.T., Morin,
P.J., Vogelstein, B., and Kinzler, K.W. (1998). Identification of c-MYC as a target of
the APC pathway. Science 281, 1509-1512.
39. Watson, S.A., and Smith, A.M. (2001). Hypergastrinemia promotes adenoma
progression in the APC(Min-/+) mouse model of familial adenomatous polyposis.
Cancer Res 61, 625-631.
40. Zhang, T., Otevrel, T., Gao, Z., Ehrlich, S.M., Fields, J.Z., and Boman, B.M. (2001).
Evidence that APC regulates survivin expression: a possible mechanism contributing
to the stem cell origin of colon cancer. Cancer Res 61, 8664-8667.
41. Hlubek, F., Jung, A., Kotzor, N., Kirchner, T., and Brabletz, T. (2001). Expression of
the invasion factor laminin gamma2 in colorectal carcinomas is regulated by beta-
catenin. Cancer Res 61, 8089-8093.
42. Roose, J., Molenaar, M., Peterson, J., Hurenkamp, J., Brantjes, H., Moerer, P., van
de Wetering, M., Destree, O., and Clevers, H. (1998). The Xenopus Wnt effector
XTcf-3 interacts with Groucho-related transcriptional repressors. Nature 395, 608-
612.
1. Introduction 23
43. Cavallo, R.A., Cox, R.T., Moline, M.M., Roose, J., Polevoy, G.A., Clevers, H., Peifer,
M., and Bejsovec, A. (1998). Drosophila Tcf and Groucho interact to repress
Wingless signalling activity. Nature 395, 604-608.
44. Valenta, T., Lukas, J., and Korinek, V. (2003). HMG box transcription factor TCF-4's
interaction with CtBP1 controls the expression of the Wnt target Axin2/Conductin in
human embryonic kidney cells. Nucleic Acids Res 31, 2369-2380.
45. Cuilliere-Dartigues, P., El-Bchiri, J., Krimi, A., Buhard, O., Fontanges, P., Flejou, J.F.,
Hamelin, R., and Duval, A. (2006). TCF-4 isoforms absent in TCF-4 mutated MSI-H
colorectal cancer cells colocalize with nuclear CtBP and repress TCF-4-mediated
transcription. Oncogene.
46. Brannon, M., Brown, J.D., Bates, R., Kimelman, D., and Moon, R.T. (1999). XCtBP is
a XTcf-3 co-repressor with roles throughout Xenopus development. Development
126, 3159-3170.
47. Hamada, F., and Bienz, M. (2004). The APC tumor suppressor binds to C-terminal
binding protein to divert nuclear beta-catenin from TCF. Dev Cell 7, 677-685.
48. Chen, G., Fernandez, J., Mische, S., and Courey, A.J. (1999). A functional interaction
between the histone deacetylase Rpd3 and the corepressor groucho in Drosophila
development. Genes Dev 13, 2218-2230.
49. Schweizer, L., Nellen, D., and Basler, K. (2003). Requirement for Pangolin/dTCF in
Drosophila Wingless signaling. Proc Natl Acad Sci U S A 100, 5846-5851.
50. Daniels, D.L., and Weis, W.I. (2005). Beta-catenin directly displaces Groucho/TLE
repressors from Tcf/Lef in Wnt-mediated transcription activation. Nat Struct Mol Biol
12, 364-371.
51. Chinnadurai, G. (2002). CtBP, an unconventional transcriptional corepressor in
development and oncogenesis. Mol Cell 9, 213-224.
52. Graham, T.A., Weaver, C., Mao, F., Kimelman, D., and Xu, W. (2000). Crystal
structure of a beta-catenin/Tcf complex. Cell 103, 885-896.
53. Kramps, T., Peter, O., Brunner, E., Nellen, D., Froesch, B., Chatterjee, S., Murone,
M., Zullig, S., and Basler, K. (2002). Wnt/wingless signaling requires BCL9/legless-
mediated recruitment of pygopus to the nuclear beta-catenin-TCF complex. Cell 109,
47-60.
54. Städeli, R., and Basler, K. (2005). Dissecting nuclear Wingless signalling: recruitment
of the transcriptional co-activator Pygopus by a chain of adaptor proteins. Mech Dev
122, 1171-1182.
55. Brembeck, F.H., Schwarz-Romond, T., Bakkers, J., Wilhelm, S., Hammerschmidt, M.,
and Birchmeier, W. (2004). Essential role of BCL9-2 in the switch between beta-
catenin's adhesive and transcriptional functions. Genes Dev 18, 2225-2230.
56. Barker, N., Hurlstone, A., Musisi, H., Miles, A., Bienz, M., and Clevers, H. (2001). The
chromatin remodelling factor Brg-1 interacts with beta-catenin to promote target gene
activation. Embo J 20, 4935-4943.
57. Hecht, A., Litterst, C.M., Huber, O., and Kemler, R. (1999). Functional
characterization of multiple transactivating elements in beta-catenin, some of which
interact with the TATA-binding protein in vitro. J Biol Chem 274, 18017-18025.
58. Hecht, A., Vleminckx, K., Stemmler, M.P., van Roy, F., and Kemler, R. (2000). The
p300/CBP acetyltransferases function as transcriptional coactivators of beta-catenin
in vertebrates. Embo J 19, 1839-1850.
59. Takemaru, K.I., and Moon, R.T. (2000). The transcriptional coactivator CBP interacts
with beta-catenin to activate gene expression. J Cell Biol 149, 249-254.
60. Mosimann, C., Hausmann, G., and Basler, K. (2006). Parafibromin/Hyrax activates
Wnt/Wg target genes by direct association with beta-catenin/Armadillo. Cell, in press.
61. Kim, S., Xu, X., Hecht, A., and Boyer, T.G. (2006). Mediator is a transducer of
Wnt/beta -catenin signaling. J Biol Chem., in press.
62. Thompson, B.J. (2004). A complex of Armadillo, Legless, and Pygopus coactivates
dTCF to activate wingless target genes. Curr Biol 14, 458-466.
63. Cox, R.T., Pai, L.M., Kirkpatrick, C., Stein, J., and Peifer, M. (1999). Roles of the C
terminus of Armadillo in Wingless signaling in Drosophila. Genetics 153, 319-332.
64. Ma, H., Nguyen, C., Lee, K.S., and Kahn, M. (2005). Differential roles for the
coactivators CBP and p300 on TCF/beta-catenin-mediated survivin gene expression.
Oncogene 24, 3619-3631.
1. Introduction 24
65. Sims, R.J., 3rd, Belotserkovskaya, R., and Reinberg, D. (2004). Elongation by RNA
polymerase II: the short and long of it. Genes Dev 18, 2437-2468.
66. Kim, Y.J., Bjorklund, S., Li, Y., Sayre, M.H., and Kornberg, R.D. (1994). A
multiprotein mediator of transcriptional activation and its interaction with the C-
terminal repeat domain of RNA polymerase II. Cell 77, 599-608.
67. Kelleher, R.J., 3rd, Flanagan, P.M., and Kornberg, R.D. (1990). A novel mediator
between activator proteins and the RNA polymerase II transcription apparatus. Cell
61, 1209-1215.
68. Flanagan, P.M., Kelleher, R.J., 3rd, Sayre, M.H., Tschochner, H., and Kornberg, R.D.
(1991). A mediator required for activation of RNA polymerase II transcription in vitro.
Nature 350, 436-438.
69. Malik, S., and Roeder, R.G. (2005). Dynamic regulation of pol II transcription by the
mammalian Mediator complex. Trends Biochem Sci 30, 256-263.
70. Conaway, J.W., Florens, L., Sato, S., Tomomori-Sato, C., Parmely, T.J., Yao, T.,
Swanson, S.K., Banks, C.A., Washburn, M.P., and Conaway, R.C. (2005). The
mammalian Mediator complex. FEBS Lett 579, 904-908.
71. Conaway, R.C., Sato, S., Tomomori-Sato, C., Yao, T., and Conaway, J.W. (2005).
The mammalian Mediator complex and its role in transcriptional regulation. Trends
Biochem Sci 30, 250-255.
72. Sierra, J., Yoshida, T., Joazeiro, C.A., and Jones, K.A. (2006). The APC tumor
suppressor counteracts beta-catenin activation and H3K4 methylation at Wnt target
genes. Genes Dev 20, 586-600.
73. Bauer, A., Huber, O., and Kemler, R. (1998). Pontin52, an interaction partner of beta-
catenin, binds to the TATA box binding protein. Proc Natl Acad Sci U S A 95, 14787-
14792.
74. Bauer, A., Chauvet, S., Huber, O., Usseglio, F., Rothbacher, U., Aragnol, D., Kemler,
R., and Pradel, J. (2000). Pontin52 and reptin52 function as antagonistic regulators of
beta-catenin signalling activity. Embo J 19, 6121-6130.
75. Rottbauer, W., Saurin, A.J., Lickert, H., Shen, X., Burns, C.G., Wo, Z.G., Kemler, R.,
Kingston, R., Wu, C., and Fishman, M. (2002). Reptin and pontin antagonistically
regulate heart growth in zebrafish embryos. Cell 111, 661-672.
76. Feng, Y., Lee, N., and Fearon, E.R. (2003). TIP49 regulates beta-catenin-mediated
neoplastic transformation and T-cell factor target gene induction via effects on
chromatin remodeling. Cancer Res 63, 8726-8734.
77. Thompson, B., Townsley, F., Rosin-Arbesfeld, R., Musisi, H., and Bienz, M. (2002). A
new nuclear component of the Wnt signalling pathway. Nat Cell Biol 4, 367-373.
78. Tolwinski, N.S., and Wieschaus, E. (2004). A nuclear escort for beta-catenin. Nat Cell
Biol 6, 579-580.
79. Hoffmans, R., Stadeli, R., and Basler, K. (2005). Pygopus and legless provide
essential transcriptional coactivator functions to armadillo/beta-catenin. Curr Biol 15,
1207-1211.
80. Narlikar, G.J., Fan, H.Y., and Kingston, R.E. (2002). Cooperation between complexes
that regulate chromatin structure and transcription. Cell 108, 475-487.
81. Tutter, A.V., Fryer, C.J., and Jones, K.A. (2001). Chromatin-specific regulation of
LEF-1-beta-catenin transcription activation and inhibition in vitro. Genes Dev 15,
3342-3354.
82. Myers, L.C., and Kornberg, R.D. (2000). Mediator of transcriptional regulation. Annu
Rev Biochem 69, 729-749.
83. Malik, S., and Roeder, R.G. (2000). Transcriptional regulation through Mediator-like
coactivators in yeast and metazoan cells. Trends Biochem Sci 25, 277-283.
84. Rozenblatt-Rosen, O., Hughes, C.M., Nannepaga, S.J., Shanmugam, K.S.,
Copeland, T.D., Guszczynski, T., Resau, J.H., and Meyerson, M. (2005). The
parafibromin tumor suppressor protein is part of a human Paf1 complex. Mol Cell Biol
25, 612-620.
85. Yart, A., Gstaiger, M., Wirbelauer, C., Pecnik, M., Anastasiou, D., Hess, D., and Krek,
W. (2005). The HRPT2 tumor suppressor gene product parafibromin associates with
human PAF1 and RNA polymerase II. Mol Cell Biol 25, 5052-5060.
86. Krogan, N.J., Dover, J., Wood, A., Schneider, J., Heidt, J., Boateng, M.A., Dean, K.,
Ryan, O.W., Golshani, A., Johnston, M., Greenblatt, J.F., and Shilatifard, A. (2003).
1. Introduction 25
The Paf1 complex is required for histone H3 methylation by COMPASS and Dot1p:
linking transcriptional elongation to histone methylation. Mol Cell 11, 721-729.
87. Shi, Y., Sawada, J., Sui, G., Affar el, B., Whetstine, J.R., Lan, F., Ogawa, H., Luke,
M.P., Nakatani, Y., and Shi, Y. (2003). Coordinated histone modifications mediated
by a CtBP co-repressor complex. Nature 422, 735-738.
88. Bienz, M. (2002). The subcellular destinations of APC proteins. Nat Rev Mol Cell Biol
3, 328-338.
89. Henderson, B.R., and Fagotto, F. (2002). The ins and outs of APC and beta-catenin
nuclear transport. EMBO Rep 3, 834-839.
90. van de Wetering, M., Sancho, E., Verweij, C., de Lau, W., Oving, I., Hurlstone, A.,
van der Horn, K., Batlle, E., Coudreuse, D., Haramis, A.P., Tjon-Pon-Fong, M.,
Moerer, P., van den Born, M., Soete, G., Pals, S., Eilers, M., Medema, R., and
Clevers, H. (2002). The beta-catenin/TCF-4 complex imposes a crypt progenitor
phenotype on colorectal cancer cells. Cell 111, 241-250.
2. Results & Discussion 26
2. Results & Discussion
2.1 Identification and in vivo role of the Armadillo-legless interaction
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2.1.1 Unpublished experiments supplemental to 'Identification and in
vivo role of the Armadillo-Legless interaction' (Hoffmans and
Basler, 2004).
In Hoffmans and Basler (2004) we showed that amino acid D164 of !-catenin and Armadillo
(Arm) is important for BCL9 and Legless (Lgs) binding, respectively. Furthermore, Arm which
can no longer bind Lgs was severely comprised in its signalling function in vivo. We wanted to
confirm these results in an in vitro signalling assay in both Drosophila and mammalian tissue
culture cells. To test the signalling dependence of Arm for Lgs binding, the activities of
Arm
S10
-wt and Arm
S10
-D164A were compared in Drosophila S2 cells. Arm
S10
-wt is a very
potent activator of the wf-luciferase reporter (Hoffmans et al., 2005), whereas Arm
S10
-D164A
is not (Figure IA). This matches very well with the in vivo results, where overexpression of
Arm
S10
-wt leads to gain of function phenotype (naked cuticle) while Arm
S10
-D164A does not.
Similar results were obtained for !-catenin in 293T cells. In order to bypass potential
interference of the endogenous protein in this system, we made use of a UAS-luciferase
reporter (Hoffmans et al., 2005). !-catenin was fused to the DNA binding domain of Gal4
(G4DBD-!-catenin) and led to strong transcriptional activation of the reporter. In contrast, the
D164A version was severely impaired in this activation (Figure IB). This suggests that in both
Drosophila as well as mammalian tissue culture cells Arm and !-catenin are dependent on
Lgs and BCL9 binding for transcriptional activation.
Hoffmans, R., Stadeli, R. and Basler, K. (2005). Pygopus and legless provide essential
transcriptional coactivator functions to armadillo/beta-catenin. Curr Biol 15, 1207-11.
Figure I: Arm and !-catenin depend on Lgs and BCL9 binding for signalling.
(A) Drosophila S2 cells were transfected in 24 well-plates with 4 "g DNA per 3 wells (200 ng wf-luciferase, 200 ng
actin5c-renilla, 200 ng tubulin"1-Gal4, 3.2 "g empty vector and 200 ng of either UAS-Arm
S10
 construct). Whereas
Arm
S10
-wt can strongly activate the reporter, Arm
S10
-D164A cannot as measured after 48 hours.
(B) Human embryonic kidney 293T cells were transfected in 12-well plates with 1.5 "g of DNA per 3 wells (500 ng
UAS-luciferase, 100 ng pRL-TK (Promega), 400 ng empty vector and 500 ng of either G4DBD constructs).
Constitutively active (S33Y) mouse !-catenin bound to the Gal4 DNA binding domain (G4DBD-!-catenin-wt)
causes a robust activation of the UAS-luciferase reporter as measured after 48 hours. However, the BCL9 binding
mutant (G4DBD-!-catenin-D164A) shows strongly reduced activity.
Error bars represent standard deviations of triplicates. Expression levels among the different Arm and !-catenin
constructs were equal as measured by western blotting (data not shown).
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2.2 Pygopus and Legless provide essential transcriptional coactivator
functions to Armadillo/!-catenin
Raymond Hoffmans
1
, Reto Städeli
1
 and Konrad Basler (2005)
Curr Biol. 15, 1207-1211.
1
 These authors contributed equally to this work and should be considered co-first
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2.2.1 Unpublished experiments supplemental to 'Pygopus and legless
provide essential transcriptional coactivator functions to
armadillo/!-catenin' (Hoffmans et al, 2005).
Townsley et al. (2004) showed that expression of an Armadillo (Arm) protein with a nuclear
localization signal (NLS) can partially 'rescue' the embryonic lawn of denticle phenotype of
legless (lgs) and pygopus (pygo) mutants. Based on this result, the authors suggested that
Lgs and Pygo can function as a nuclear anchor for Arm/!-catenin. We reasoned that if the
sole function of Lgs and Pygo is to act as a nuclear anchor then NLS-Arm signalling activity
should be completely independent of Lgs or Pygo, since the NLS will make Arm always
nuclear. To test our hypothesis, the signalling capacity of different forms of NLS-Arm were
compared in Drosophila S2 cells in the presence or absence of Lgs and Pygo. Expression of
NLS-Arm leads to strong transcriptional activation of the wf-luciferase reporter gene. This
activation is partially dependent on Lgs and Pygo since RNAi against these proteins results in
reduced activation (Figure II). Additionally, NLS-Arm protein which is mutant for Lgs binding
(NLS-Arm-D164A) also has reduced activity. This suggests that although NLS-Arm is
predominantly nuclear, Lgs and Pygo facilitate extra transcriptional activation to NLS-Arm.
Figure II: NLS-Arm depends on both Lgs binding and the C-terminus of Arm for signalling.
Drosophila S2 cells were transfected in 96 well-plates with 2 "g DNA per 12 wells (200 ng wf-luciferase, 400
ng actin5c-renilla, 1.2 "g empty vector and 200 ng of either NLS-Arm construct) and 1 "g dsRNA per well.
Whereas NLS-Arm can strongly activate the reporter, NLS-Arm-D164A is less active as is NLS-Arm-!C. A
NLS-Arm-D164A-!C is completely signalling inactive. Relative reporter gene activity measured after 48 hours.
Error bars represent standard deviations of triplicates. In cl8 cells all 4 NLS-Arm constructs are expressed
equally well as measured by western blotting (data not shown)
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One likely explanation for the ability of NLS-Arm to signal in the absence of Lgs and
Pygo is that NLS-Arm can bind other proteins such as CBP/p300, Brg1 and Parafibromin
through its C-terminal half (Barker et al., 2001; Hecht et al., 2000; Takemaru and Moon, 2000;
Mosimann et al submitted). These proteins have been implicated in chromatin remodeling
and transcriptional initiation/elongation (see 1. Introduction for more details). If NLS-Arm
signals in the absence of Lgs or Pygo through these C-terminal binding proteins then deletion
of the C-terminus should inhibit transcriptional activity. As can be seen in Figure II, deletion of
the C-terminus (NLS-Arm-!C) reduces the transcriptional output of NLS-Arm. Signalling of
NLS-Arm-!C can be further inhibited by RNAi against Lgs or Pygo and is completely
abrogated in a double mutant for both Lgs binding and the C-terminal deletion (NLS-Arm-
D164A-!C). This led us to conclude that the signalling of NLS-Arm in lgs and pygo mutants
as seen by Townsley et al. (2004) is dependent on the C-terminus of Arm.
The above described experiment shows that the transactivation activity of Arm
depends on Lgs binding and on an intact C-terminal region for signalling. In Chapter 2.5 of
this thesis experiments are described that try to decipher what the contribution is of Lgs
versus the C-terminal domain for Wg/Wnt signalling.
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2.3 The roles of BCL9.2 and tyrosine phosphorylation of Armadillo/!-
catenin in Wingless/Wnt signalling.
Raymond Hoffmans and Konrad Basler
in preparation
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The Armadillo (Arm)/!-catenin protein has a dual function. On the one hand Arm/!-catenin
binds "-catenin and the cytoplasmic tail of E-cadherin thereby forming the adherens junctions
(Drees et al., 2005; Yamada et al., 2005). On the other hand it is the key effector protein of
the Wingless (Wg)/ Wnt signalling pathway. Arm/!-catenin that is not part of the adherens
junctions is degraded in the absence of the Wg/Wnt ligand. This degradation is initiated by
the binding of Arm/!-catenin to its destruction complex consisting of Adenomatous Polyposis
Coli (APC), Axin, Casein Kinase I" and GSK-3!. The latter two phosphorylate !-catenin,
which then is ubiquitinated and sent to the proteasome for degradation (Aberle et al., 1997;
Behrens et al., 1998; Ikeda et al., 1998; Kishida et al., 1998; Liu et al., 2002). When the
Wg/Wnt ligand is present, it binds the receptor Frizzled which together with Arrow/LRP
signals through Dishevelled to inhibit the formation of the destruction complex. As a
consequence, Arm/!-catenin accumulates in the cytoplasm and subsequently enters the
nucleus where it binds members of the TCF/Lef family of DNA binding transcription factors
(Behrens et al., 1996; Brunner et al., 1997; Riese et al., 1997; van de Wetering et al., 1997).
In the nucleus !-catenin interacts with additional proteins such as CBP/p300, Parafibromin
and Legless (Lgs)/BCL9 (Hecht et al., 2000; Kramps et al., 2002; Takemaru and Moon, 2000,
Mosimann et al. unpublished). The latter can also bind with Pygopus (Pygo). While Pygo is
necessary for Wg signalling, the role of Pygo in the transcription of Wg/Wnt target genes is
still largely unknown (Belenkaya et al., 2002; Kramps et al., 2002; Parker et al., 2002; Stadeli
and Basler, 2005; Thompson et al., 2002; Thompson, 2004). A chimeric protein in which the
Lgs interaction domain of Pygo (PHD) has been replaced by the !-catenin interaction domain
of Lgs (HD2) can rescue both lgs and pygo mutant flies suggesting that the primary function
of Lgs is the recruitment of Pygo to Arm/!-catenin (Kramps et al., 2002; Thompson, 2004).
Two recent reports describe the cloning and functional analysis of a second ortholog
of Lgs in mammals, BCL9.2. This protein was discovered in two different yeast two-hybrid
screens to identify new binding partners of !-catenin (Adachi et al., 2004; Brembeck et al.,
2004). Binding of BCL9.2 to !-catenin depends on tyrosine 142 (Y142) of !-catenin, since
mutating this amino acid abrogated the binding (Brembeck et al., 2004). In contrast to BCL9,
it was shown that BCL9.2 does not depend on Pygo binding for its transactivation activity
(Adachi et al., 2004; Brembeck et al., 2004).
In the present study we report that Y142 of !-catenin/Arm is not important for either
BCL9, BCL9.2 or Lgs binding. However the BCL9.2-!-catenin interaction is dependent on the
aspartic acid 164 (D164) of !-catenin/Arm. We demonstrate that Arm (Drosophila homolog of
!-catenin) does not depend on Y142 for Wg signalling in vivo in Drosophila. In addition !-
catenin does not depend on Y142 in Wnt signalling assays in mammalian tissue culture cells.
We also show that BCL9.2 can functionally replace Lgs both in tissue culture and in vivo in
Drosophila and that this rescue is dependent on Pygo binding.
2. Results & Discussion 46
Results
Tyrosine phosphorylation of Arm/!-catenin is not necessary for BCL9.2 binding
Recently there was a report that put forth a model in which !-catenin Y142 needs to be
phosporylated for BCL9.2 binding (Brembeck et al., 2004). We previously identified two amino
acids on !-catenin/Arm, D162 and D164, that are necessary for BCL9/Lgs binding (Hoffmans
and Basler, 2004). We therefore wanted to know if D164 is also important for BCL9.2 binding
and if Y142 has an influence on BCL9/Lgs binding. To test this, !-catenin mutants were used
in a quantitative yeast two-hybrid assay for binding to BCL9, BCL9.2 or "-catenin. Mutation of
the aspartic acid D164 of !-catenin to alanine (D164A), which is crucial for BCL9-!-catenin
interaction, also abolished the binding to BCL9.2. !-catenin-Y142 mutated to alanine (Y142A)
did not affect binding of BCL9 but abolished binding of "-catenin (Figure 1A and Aberle et al.,
1996; Pokutta and Weis, 2000). Surprisingly, in contrast to previous results Y142A also did
not affect binding of BCL9.2 (Brembeck et al., 2004). The aromatic ring of Y142 is important
for "-catenin binding (Pokutta and Weis, 2000). By changing Y142 to a phenylalanine
(Y142F), the necessity of the free hydroxyl group of Y142 was determined. Y142F had no
significant effect on either BCL9, BCL9.2 or "-catenin binding (Figure 1A and Aberle et al.,
1996)). In order to mimic phosphorylation, Y142 was replaced by an aspartic or glutamic acid
(Y142D and Y142E respectively). This also had no effect on !-catenin binding to BCL9, but
BCL9.2 did bind slightly better, whereas Y142D and Y142E abolished "-catenin binding.
Corresponding mutations were introduced in Arm and tested for binding to Drosophila
homologues and BCL9.2 (Figure 1B). The results were the same as for the mammalian
components, with the exception that Drosophila "-catenin binds better to Arm-Y142A than "-
catenin to !-catenin-Y142A. Together these binding studies suggest that the BCL9, BCL9.2
and Lgs interaction with !-catenin/Arm requires amino acid D164, whereas amino acid Y142
is important for "-catenin binding but not for BCL9, BCL9.2 or Lgs binding.
Arm-Y142 mutants can rescue arm null animals
To investigate if an Arm-Y142A mutant has impaired transcriptional activition in Drosophila
we tested if Arm-Y142A can substitute for wildtype Arm in vivo by performing a rescue assay
with an arm allele. For this purpose we used the arm
2a9
 allele, which has a frameshift
mutation in Arm repeat 3 and is presumed to be a null allele (Peifer and Wieschaus, 1990).
Hemizygous arm
2a9
 males die as embryos but can be rescued to adults by an Arm-wt
transgene driven by the tubulin"1 promoter without any obvious phenotypes (Table 1 and
(Hoffmans and Basler, 2004)). In contrast, a tubulin"1-promoter-driven Arm-D164A transgene
cannot rescue arm
2a9
 mutants and the males die as embryos or early larvae (Table 1 and
(Hoffmans and Basler, 2004). An Arm-Y142A transgene can rescue arm
2a9
 males to adults
although not as efficiently as Arm-wt. The rescued males do not show any obvious
phenotypes (Table 1).
2. Results & Discussion 47
Constitutively active signalling of Arm
S10
 does not depend on tyrosine 142
The results from the binding and rescue experiments suggest that Y142 in Arm is necessary
for adhesion but not signalling. Hence we wanted to test the Y142A mutation in a signalling
assay which is not adhesion dependent. !-catenin/Arm mutants that have N-terminal
truncations which delete the GSK-3! phosphorylation sites are degradation resistant and
therefore overactivate the Wg signalling pathway (Pai et al., 1996). One of these constitutively
active forms is Arm
S10
, which has an N-terminal in-frame deletion but can still bind "-catenin.
Figure 1: !-catenin/Arm-D164 is important for BCL9/Lgs and BCL9.2 binding, whereas !-catenin/Arm-
Y142 is crucial for "-catenin binding.
Using a quantitative yeast two-hybrid assay the interactions of !-catenin and Armadillo mutants with
BCL9, Lgs, BCL9.2, "-catenin and Pangolin (Pan) were tested. The transcription factor Huckebein (Hkb)
(Bronner et al., 1994), which plays no role in Wnt/Wg signalling, served as a negative control.
(A) !-catenin mutants were tested for binding with BCL9, BCL9.2 and "-catenin. The D164A mutation
abrogated binding to BCL9 and BCL9.2. The Y142 mutations do not affect binding to BCL9 or BCL9.2,
suggesting that the residue itself, as well as its phosphorylation, is not necessary for BCL9 and BCL9.2
binding. However mutations of Y142 (except Y142F) do abolish "-catenin binding.
(B) Arm mutants were tested for binding with Lgs, BCL9.2, Drosophila "-catenin and Pan. The D164A
mutation severely affects binding of Lgs and BCL9.2. The Y142A mutation however affects mainly
Drosophila "-catenin binding and not Lgs or BCL9.2.
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Ubiquitous expression in the embryo of an Arm
S10
-wt transgene (driven by daughterless-Gal4)
suppresses denticle formation and results in a naked cuticle (Figure 2B and (Hoffmans and
Basler, 2004)). This Wg gain of function phenotype is completely abolished when the Lgs
binding mutant (Arm
S10
-D164A)  is used (Figure 2D and (Hoffmans and Basler, 2004)). The
Y142 mutant (Arm
S10
-Y142A) shows a similar gain of signalling activity as Arm
S10
-wt (Figure
2C). Thus, constitutive Arm
S10
 depends on intact D164 but not Y142 for its function. We
deduce from this data that Y142 is not essential for transcriptional activity in vivo in
Drosophila.
!-catenin is not dependent on tyrosine 142 for signalling in vitro
The experiments presented above suggest that Y142 of Arm is not necessary for Wg
signalling in Drosophila. In order to test the effect of this mutation in !-catenin on signalling,
different forms of constitutively active !-catenin (S33Y) fused to the DNA binding domain of
Gal4 (G4DBD-S33Y) were compared using UAS-luciferase as a read out (Hoffmans et al.,
2005). In Human embryonic kidney 293 (HEK293) cells, which express low levels of BCL9.2
(Adachi et al., 2004; Brembeck et al., 2004), addition of G4DBD-S33Y-wt caused strong
transcriptional activation of the reporter. The D164A form, which cannot bind BCL9 and
BCL9.2 is much less active. In contrast, !-catenin-Y142A is as active the wildtype form.
Additionally, mimicking phosphorylation by changing Y142 to glutamic acid or aspartic acid
had no consequences for activation (Figure 3A). Similar results were obtained in SW480 cells
(Figure 3B) which have high levels of BCL9.2 (Adachi et al., 2004). This suggests that Y142
of !-catenin is not essential for Wnt signalling in mammalian tissue culture cells.
Females heterozygous for arm
2a9
 were crossed with males carrying different tubulin"1-promoter-
driven rescue constructs. The percentage of rescued males containing both the arm
2a9
 allele and the
tubulin"1 rescue construct are shown. n indicates the male progeny that contain the tubulin"1
rescue construct but inherited the wild-type arm allele from the balancer chromosome instead of the
arm
2a9
 allele and therefore corresponds to the expected number of arm
2a9
 males with the tubulin"1
rescue construct.
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Both BCL9.2 and BCL9 can functionally replace Lgs in Drosophila tissue culture cells
and in vivo
It was previously shown that BCL9.2, in contrast to BCL9 and Lgs, does not depend on Pygo
binding in order to function as a transcriptional activator (Adachi et al., 2004; Brembeck et al.,
2004). To further explore the independence of BCL9.2 function on Pygo binding we examined
the significance of the interaction in vivo for Wg signalling. We first addressed whether
BCL9.2 can, similar to BCL9, replace Lgs in tissue culture cells and flies. In Drosophila S2
cells, after RNAi mediated knock-down of Lgs, signalling rescuing activity of BCL9 and
BCL9.2 was measured with wf-luciferase (Hoffmans et al., 2005)(Figure 4). BCL9 can very
effectively rescue signalling activity in the absence of Lgs and this is dependent on Pygo
binding since a Pygo binding mutant BCL9 (BCL9!HD1, Kramps et al., 2002) cannot rescue.
The BCL9.2 protein can also rescue signalling activity although not as efficiently as BCL9
(Figure 4). This is not depending on the BCL9.2 nuclear localization signal as deletion of this
signal (BCL9.2!138-173, Brembeck et al., 2004) has no influence and is as active as full
length BCL9.2. However, the ability of BCL9.2 to replace Lgs is also dependent on Pygo
binding because a mutant for Pygo binding (BCL9.2!PyBD, Brembeck et al., 2004 and data
not shown) is not able to rescue signalling activity.
BCL9 when driven by a tubulin"1-promoter has been shown to be able to rescue
viability and limb pattern of lgs
17E
/lgs
21L
 animals, which normally die as pharate adults
Figure 2: The Y142A mutation does not affect transcriptional activity of a constitutively active Arm
(A) The cuticle of a wildtype embryo where denticle bands alternate with naked cuticle corresponding to the
alternating pattern of Wg pathway activity.
(B) Ubiquitous expression of a constitutively active Arm (Arm
S10
) results in overactivation of the pathway,
which can be seen by the ectopic naked cuticle.
(C) Ubiquitous expression of Arm
S10
 carrying the Y142A mutation leads to a similar gain of function phenotype
as Arm
S10
-wt.
(D) Ubiquitous expression of Arm
S10
 carrying the D164A mutation does not lead to a naked cuticle. It does
show a slight dominant negative effect (ectopic denticles at regions that are normally naked).
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(Kramps et al., 2002). To explore the possibility if BCL9.2 could be a functional homolog of
Lgs, tubulin"1-promoter driven transgenes of BCL9.2 and BCL9.2!PyBD were generated.
BCL9.2 can rescue lgs
17E
/lgs
21L
 animals, but this rescue is dependent on Pygo binding since
BCL9.2!PyBD cannot rescue these animals (data not shown). These results suggest that
BCL9.2, like BCL9, is a functional homologue of Lgs and that BCL9.2 needs to bind Pygo for
its function.
Discussion
Members of the Wg/Wnt family are secreted signalling molecules that have a crucial role in
developmental processes by regulating the transcription of their target genes. Aberrant
Figure 3: !-catenin-Y142 is not important for signalling in mammalian tissue culture cells
There is no difference in signalling activity between !-catenin-wt or a Y142 mutant in cells with
low (HEK293) or high (SW480) BCL9.2 levels.
(A) HEK293 cells were transfected with constitutively active (S33Y) mouse !-catenin bound to the
Gal4 DNA binding domain (G4DBD-S33Y). Wildtype causes a robust activation of the UAS-
luciferase reporter. However, the D164A form, which is mutant for BCL9 and BCL9.2 binding,
shows strongly reduced activity. The mutants for Y142 are as similarly active as wildtype.
(B) The outcome of the SW480 cell experiment is identical to (A)
Error bars represent standard deviations of triplicates. All !-catenin proteins were equally
expressed as measured by western blotting (data not shown).
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activation of the Wnt signalling pathway has been casually linked to human diseases and
cancer (reviewed by Moon et al., 2004). Arm/!-catenin, the effector protein of the pathway, is
post-transcriptionally upregulated, accumulates in the cytoplasm and enters the nucleus.
There it binds to the DNA binding protein TCF/Lef and to BCL9 which recruits Pygopus to the
complex. In this report we provide evidence that binding of BCL9, BCL9.2 and Lgs is not
dependent on Y142 of Arm/!-catenin. Single amino acid substitutions of Y142 had no effect
on Arm/!-catenin transcriptional activity both in vivo and in tissue culture cells. In addition we
show that BCL9.2 can functionally replace Lgs in Drosophila S2 cells and in vivo and that this
is dependent on Pygo binding.
It was previously reported that BCL9.2 interacted with ! -catenin in a tyrosine
phosphorylation dependent manner. This interaction was dependent on the presence of an
active receptor tyrosine kinase. Furthermore, mutation of !-catenin-Y142 to alanine
abrogated binding to BCL9.2 in this modified yeast two-hybrid system (Brembeck et al.,
2004). In contrast, our binding studies show that Arm/!-catenin binding to BCL9.2 is not
dependent on Y142. In agreement with our results, BCL9.2 was also identified as a !-catenin
binding partner in a standard yeast two-hybrid system (Adachi et al., 2004) which lacks
receptor tyrosine kinases. One explanation to account for the discrepancy between the two
results may be attributed to the use of different lengths of !-catenin proteins in the binding
assays. While we used full length !-catenin, the other groups used truncated versions of the
Figure 4: BCL9.2 can functionally replace lgs in S2 cells
(A) In S2 cells BCL9 can rescue Lgs RNAi as measured by the wf-luciferase reporter. This is
dependent on the ability of BCL9 to bind Pygo since a binding mutant (BCL9!HD1) cannot rescue.
BCL9.2 can partially rescue Lgs RNAi. This is not dependent on the intrinsic NLS of BCL9.2
(BCL9.2!138-173) but is dependent on Pygo binding (BCL9.2!PyBD). To activate the pathway,
cells were cocultured with Wg-secreting cells (van Leeuwen et al., 1994), which resulted in a 20-fold
stimulation of the wf-luciferase (data not shown). The rescue activity of the different BCL9 and
BCL9.2 proteins is represented relative to the respective GFP RNAi negative control.
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protein. Our hypothesis is that full length !-catenin more accurately reflects the in vivo
situation.
The arm
2a9
 allele is the strongest arm allele available and has both a defect in
adhesion function as well as in Wg signalling (Peifer et al., 1993; Peifer and Wieschaus,
1990). An Arm-Y142A transgene was able to rescue arm
2a9
 males but not as efficiently as an
Arm-wt transgene. The binding studies suggest that Arm-Y142A has reduced "-catenin
binding. One possible explanation for the reduced efficiency seen with Arm-Y142A could be
that the adhesion defect of arm
2a9
 allele is not overcome completely.
BCL9.2 cannot rescue Lgs RNAi as efficiently as BCL9, this could be due to different
binding affinities of BCL9 and BCL9.2 for Arm and/or Pygo. In this scenario, BCL9.2 has a
lower binding affinity for Arm and/or Pygo than BCL9 and therefore the rescue by BCL9.2
would be less efficient. Consistent with this, in our yeast two-hybrid experiments we did notice
that BCL9.2 bound less well to !-catenin then BCL9 did (data not shown), although it must be
said that this is not a precise way of comparing binding affinities of different proteins.
We show that BCL9.2 is a functional homolog of Lgs and depends on Pygo binding
for its rescue activity in flies. However, Adachi et al (2004) showed that in mammalian cells
BCL9.2 is not dependent on Pygo binding for signalling but that it is dependent on the C-
terminus of BCL9.2. At the amino acid level BCL9 and BCL9.2 have three highly homologues
regions of 20-30 amino acids in their C-terminus (Adachi et al., 2004; Brembeck et al., 2004).
Interestingly, these short clusters are missing in Lgs. For Lgs it has been shown that the only
two domains important for its function are the Pygo binding domain (HD1) and the !-catenin
interaction domain (HD2). A transgene containing only HD1 and HD2 fused by a triple HA tag
could rescue lgs null mutants flies suggesting that the rest of the Lgs protein is dispensable
for its function (Kramps et al., 2002). More work is needed to determine the contribution of C-
terminus of BCL9 and BCL9.2 in Wnt signalling in vertebrates.
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Materials and methods
Plasmid constructs
Single amino acid mutations were introduced by site-directed mutagenesis (Quickchange-Kit,
Stratagene) in mouse !-catenin (amino acids 1-781) and Arm (amino acids 38-806) which
were cloned in pGAD424. Human BCL9 (amino acids 199-392), mouse "-catenin (amino
acids 1-750), human BCL9.2 (amino acids 232-427), Lgs (amino acids 364-555), Pan (amino
acids 1-129), Drosophila "-catenin (amino acids 1-394) were cloned into pBTM116 (Bartel
and Fields, 1997). All constructs were verified by sequencing.
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pcDNA3.1 (Invitrogen) or pPacPL (Koelle and Hogness, 1992) vectors were used for
expression of cDNAs in mammalian cells or S2 cells, respectively.
For simplicity, we use the amino acid numbering of !-catenin for both !-catenin and Arm
throughout the text. !-catenin Y142 and D164 would correspond to Arm Y150 and D172.
dsRNA production
Templates for GFP and Lgs dsRNA synthesis were generated by PCR using the following
primers containing 5’ T7 promoter tails:
fGFP 5'T7CTTTTCACTGGAGTTGTCC, rGFP 5'T7ATCCATGCCATGTGTAATCC, product
length: 0.68kb;
fLgs 5’T7GGCATGCGTCCACATGCC, rLgs 5’T7ATTTGTTGACAAAGAACGTTG, product
length: 0.58kb;
dsRNA was then synthesized from these templates using the Ambion Megascript kit. For
RNAi in S2 cells (Clemens et al., 2000) 1µg of dsRNA was used per well (96 well plate).
Cell culture
S2 cell transfections were performed in 96 well plates using polyethylenimine (PEI,
Polysciences, Inc) with a total of 500 ng of DNA per 3 wells (50 ng wf-luc, 100 ng actin5c-
renilla, 50 ng tubulin"1-dfrizzled2, 50 ng rescue constructs and 250 ng empty vector). The
Wg signalling pathway was induced 48 hr after transfection by adding heat-shocked S2 cells
stably transfected with Wg cDNA under the control of a heat-shock promoter (van Leeuwen et
al., 1994).
HEK293 cell transfections were performed in 24 well plates using Lipofectamine (Invitrogen)
with a total of 0.8 ug of DNA per 3 wells (300 ng UAS-luc, 100 ng pCMV-RL (Promega), 300
ng Gal4DBD constructs, 100 ng of empty vector).
HeLa cell transfections were performed in 24 well plates using Lipofectamine and PLUS
reagent (Invitrogen) with a total of 1.2 ug of DNA per 3 wells (400 ng UAS-luc, 100 ng pCMV-
RL (Promega), 600 ng G4DBD constructs, 100 ng of empty vector).
Luciferase activities were determined after 72 hr for S2 cells and after 48 hr for HEK293 and
HeLa cells using the Dual-Luciferase Assay System (Promega).
Yeast two-hybrid
The yeast two-hybrid system was used as described in chapter 3 of Bartel and Fields (1997).
Interactions between proteins were measured using the quantitative 'Liquid Culture Assay
Using ONPG as Substrate' (Clontech, Yeast Protocols Handbook, http://www.clontech.com/
clontech/Techinfo/manuals).
Transgenes
For embryonic experiments arm transgenes were expressed from UAS-constructs under
control of the daughterless-Gal4 driver (Wodarz et al., 1995). Several independent lines of
arm
S10
-wt, arm
S10
-Y142A and arm
S10
-D164A transgenes were established and tested. For
rescue experiments full-length arm transgenes were driven by the tubulin"1 (tub) promoter
(Basler and Struhl, 1994). All arm coding regions used contain a c-Myc epitope in their C-
terminal region at the same position as the original arm
S10
 (Pai et al., 1997).
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2.4 pygo double knock-out mouse embryonic fibroblasts
In order to elucidate the function of Lgs and Pygo in the Wnt pathway in a vertebrate model
organism, knock-out (KO) mice were generated by members of the lab of Michel Aguet
(ISREC, Lausanne). Mice have two paralogs of Pygo (mPygo1 and mPygo2) and the KO
constructs were designed in such a way that in both cases the NHD as well as the PHD of
Pygo was deleted. The direct KO of mPygo1 is viable and fertile and does not show any
phenotypes (after 6 months). In contrast, the direct KO of mPygo2 is lethal at E14,5. The
phenotype of the double KO of both alleles is indistinguishable from mPygo2 KO (personal
communication, Aguet lab members).
We received from the Aguet lab pygo1; pygo2 mouse embryonic fibroblasts (MEF),
generated from E13,5 embryos. A western blot showed that Pygo double KO MEFs indeed do
not have any Pygo protein (Figure III). In the same experiment the Pygo levels between 293T
(human embryonic kidney), NIH3T3 (a widely used MEF cell line) and wildtype MEFs (also
received from the Aguet lab) were compared. These three cell lines seem to express equal
amounts of Pygo protein (Figure III).
We wanted to know if Pygo has the same function in Wnt signalling in mammals as it
has in Drosophila. Therefore we tested if the pygo double knock-out cells are impaired in Wnt
signalling. The results presented below on the double KO MEFs are preliminary and should
not be considered conclusive, but they give a starting point for further experiments. A
comparison was made between the signalling capacity of !-catenin in NIH3T3, wt MEF and
pygo KO MEF cell lines. For this we made use of an UAS-luciferase reporter (Hoffmans et al.,
2005) and a constitutively active !-catenin (!N, lacking the first 129 amino acids) fused to the
DNA binding domain of Gal4 (G4DBD-!N). In the wt MEFs and in the NIH3T3 cells G4DBD-
!N-wt can strongly activate the reporter (Figure IVA and B). Adding additional Pygo has a
minimal effect on the already robust activated reporter in wt MEFs and NIH3T3 cells. In the
Figure III: pygo KO MEFs do not express Pygo protein.
Western blot on lysates show that pygo1 -/- ; pygo2 -/- MEFs do not express Pygo. Whereas, 293T, NIH3T3 and
wildtype (wt) MEF cells express equal amounts of Pygo.  For this western blot the hPygo2b antibody was used,
which is a rabbit polyclonal antibody directed against amino acid 34-189 (contains the NHD).
2. Results & Discussion 58
pygo  KO MEF cell line, DNA tethered !-catenin (G4DBD-!N-wt) led to transcriptional
activation of the reporter in the absence of Pygo (Figure IVC). When Pygo was added, this
resulted in a stronger activation of the reporter. In these signalling assays the KO MEFs
without addition of Pygo show lower signalling activity then wt MEFs and NIH3T3 (compare
fold induction of the G4DBD to G4DBD-!N-wt in all three cell lines). When Pygo is added to
the KO MEFs, these cells show a similar signalling activity as wt MEFs and NIH3T3 cells do.
In a pygo null background one would expect that G4DBD-!N-wt and G4DBD-!N-
D164A would show exactly the same level of signalling. Interestingly in the pygo KO MEF cell
line G4DBD-!N-D164A does not behave exactly the same as G4DBD-!N-wt does (Figure
IVA). The protein that no longer can bind BCL9 and BCL9.2 has a further reduced signalling
capacity compared to the protein that still can bind BCL9 and BCL9.2. This might suggest that
BCL9 and/or 9.2 have a function in nuclear Wnt signalling surpassing the recruitment of Pygo
to !-catenin. One possible explanation could be that BCL9 and/or 9.2 interfere with binding of
Figure IV: Pygopus enhances transactivation of nuclear !-catenin complex
Evaluation of !-catenin transactivation capacity in pygo KO, wildtype (wt) and NIH3T3 MEF cell lines. Relative
reporter-gene activities induced by two different versions of DNA-tethered !-catenin (G4DBD-!N-wt and D164A)
were assayed after 48 hours.
(A) In wt MEFs, G4DBD-!N-wt can strongly activate the reporter. G4DBD-!N-D164A is less active. The addition of
extra Pygo to G4DBD-!N-wt or G4DBD-!N-D164A only has a minor effect on reporter activity. Wt MEFs were
transfected in 10 cm plates with 7 "g of DNA (1 ug UAS-luciferase, 1 ug pCMV-RL (Promega), 1 ug eGFP, 2 ug
empty vector or 2 ug hPygo2 and 2 ug of either G4DBD constructs) using the nucleofector technology (Amaxa).
(B) NIH3T3 MEFs behave the same as wt MEFs. NIH3T3 MEFs were transfected in 24-well plates with 0.7 "g of
DNA per 2 wells (100 ng UAS-luciferase, 100 ng pCMV-RL (Promega), 100 ng eGFP, 200 ng empty vector or 200
ng hPygo2 and 200 ng of either G4DBD constructs) using the PLUS reagent and lipofectamine (Invitrogen). Error
bars represent standard deviations of duplicates.
(C) In pygo KO MEFs, G4DBD-!N-wt can activate the reporter. Whereas G4DBD-!N-D164A is less active. Adding
both Pygo and G4DBD-!N-wt results in enhanced activity, which is comparable to the activity of G4DBD-!N-wt in
wt MEFs. In this particular experiment adding extra Pygo also boosted the signal activity of G4DBD-!N-D164A, but
this not observed consistently. pygo KO MEFs were transfected in 10 cm plates with 7 "g of DNA (1 ug UAS-
luciferase, 1 ug pCMV-RL (Promega), 1 ug eGFP, 2 ug empty vector or 2 ug hPygo2 and 2 ug of either G4DBD
constructs) using Amaxa nucleofector technology).
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an inhibitor to !-catenin signalling. In the case of G4DBD-!N-wt this inhibitor cannot bind
because of BCL9/9.2 binding. However, in the case of G4DBD-!N-D164A which cannot bind
BCL9/9.2, the inhibitor is not prevented from binding resulting in a reduction in signalling.
Another possibility could be that BCL9.2 has transactivation activity independent of Pygo as
was suggested by Adachi et al. (2004). The extra signalling of G4DBD-!N-wt compared to
G4DBD-!N-D164A in a pygo null background would then be caused by the transactivation
activity of BCL9.2. It will be interesting to see if there is a difference in transcriptional activity
between these two !-catenin versions in a BCL9; BCL9.2 double knock-out cells.
In Drosophila S2 cells and in flies it was shown that a Pygo protein with a mutation in
the NHD domain (F78A) is not functional in signalling assays (Hoffmans et al., 2005; Stadeli
and Basler, 2005). We wanted to test in a mammalian system if disruption of the NHD is
important for Pygo function. The pygo KO MEF cell line provides an excellent opportunity to
examine this. In pygo KO MEFs addition of Pygo leads to an increase in reporter activity
(Figure IVA). However addition of Pygo-F78A or Pygo lacking amino acids 74-78 resulted in a
similar increase. Also deletion of amino acids 70-81 had only a minor effect on signalling
activity (data not shown, Figure V). This is clearly different from the situation in Drosophila
where an intact NHD is essential for Pygo function. It could be that in Drosophila an intact
NHD is more important then in mammals. It will be interesting to see if a Pygo construct that
only contains the PHD domain is as active as wt Pygo in the KO cells.
Figure V: Intact NHD domain of Pygo not important for transactivation in MEFs
Evaluation of different forms of Pygo for transactivation capacity in pygo KO MEF cell line. Relative reporter-
gene activities were measured. G4DBD-!N-wt induced the UAS-Luciferase reporter, this activity can be
enhanced by expression of Pygo-wt but also by Pygo-!74-78 and Pygo-!70-81.
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2.5 Signalling outputs of the N- and C-terminal activating arms of
Arm/!-catenin
The Arm/!-catenin protein contains three domains that are important for Wnt signalling
(Orsulic and Peifer, 1996). Arm repeats 1-4 are necessary and sufficient for binding to Lgs
(Hoffmans and Basler, 2004; Kramps et al., 2002; Stadeli and Basler, 2005), whereas Arm
repeats 3-8 are used by the DNA binding protein Pangolin/TCF/LEF (Behrens et al., 1996;
Brunner et al., 1997; Graham et al., 2000; van de Wetering et al., 1997). Finally, Arm repeats
11-12 together with the C-terminal domain (Tutter et al., 2001) are necessary for the binding
of a multitude of proteins that are involved in the transcription process, namely CBP/p300,
Parafibromin and Brg-1 (Barker et al., 2001; Hecht et al., 2000; Takemaru and Moon, 2000;
Mosimann et al submitted). We wanted to evaluate what the contributions are of Lgs binding
(Lgs branch) versus binding of C-terminal partners (C-terminal branch) to Arm/!-catenin with
respect to signalling in both Drosophila and mammals.
Arm/!-catenin with a single amino acid mutation (D164A) in Arm repeat 1 is severely
impaired in Lgs binding and in signalling. However, it was shown that Arm-D164A is
functional at the adherens junctions (Hoffmans and Basler, 2004). In Drosophila there are
several arm mutants that have a premature stop which results in a (partial) deletion of the C-
terminus (!C). These mutants have severe Wnt signalling defects but they have no adhesion
defects (Peifer et al., 1993; Peifer and Wieschaus, 1990). These arm-!C mutants are most
likely compromised in binding of CBP/p300 and Parafibromin (Takemaru and Moon, 2000;
Mosimann et al., submitted).
Figure VI: Evaluation of Lgs branch versus C-terminal branch of Arm/!-catenin in signalling.
(A) Drosophila clone 8 cells were transfected in 24 well-plates with 4 "g DNA per 3 wells (100 ng wf-
luciferase, 100 ng actin5c-renilla, 100 ng tubulin"1-Gal4, 200 ng of UAS-Arm
S10
 or vector). Arm
S10
-wt can
strongly activate the reporter (measured after 48 hours) and for this Lgs binding is necessary (Arm
S10
-D164A).
There is a lesser dependence on an intact C-terminus (Arm
S10
-!C). The double mutant is almost signalling
dead (Arm
S10
-D164A-!C).
(B) Human embryonic kidney 293 cells were transfected in 24-well plates with 0.8 "g of DNA per 3 wells (200
ng UAS-luciferase, 100 ng pCMV-RL (Promega), 300 ng empty vector and 200 ng of either G4DBD
constructs). Constitutively active (S33Y) mouse !-catenin bound to the Gal4 DNA binding domain (G4DBD-
S33Y-wt) causes a robust activation of the UAS-luciferase reporter as measured after 48 hours. However, the
mutant for BCL9 binding (G4DBD-!-catenin-D164A) shows strongly reduced activity. The C-terminal deleted
versions (G4DBD-S33Y-!C and G4DBD-S33Y-D164A-!C) are completely signalling incompetent. Expression
levels among G4DBD-S33Y constructs were equal as measured by western blotting (data not shown).
Error bars represent standard deviations of triplicates.
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The signalling capacity of different forms of constitutively active Arm (Arm
S10
) were
compared in Drosophila clone 8 cells. Arm
S10
-wt is a very potent activator of the wf-luciferase
reporter (Hoffmans et al., 2005). An Arm
S10
 version that can no longer bind Lgs (Arm
S10
-
D164A) cannot significantly activate the reporter, whereas an Arm
S10
 that is lacking the C-
terminus (Arm
S10
-!C) still retains some signalling activity. A combination of the two mutants
(Arm
S10
-D164A-!C) is completely signalling dead (Figure VIA). In agreement with this is the
NLS-Arm experiment in Drosophila S2 cells (See Figure II), which showed that NLS-Arm!C
was more active then NLS-Arm-D164A and that NLS-Arm-D164A-!C is not active at all. This
suggests that in Drosophila cells the C-terminus contributes less then Lgs binding to
signalling.
In order to compare different forms of constitutively active !-catenin (S33Y) in
HEK293 cells the UAS-luciferase reporter (Hoffmans et al., 2005) was used. !-catenin-S33Y
was fused to the DNA binding domain of Gal4 (G4DBD-S33Y-wt) and caused strong
transcriptional activation of the reporter (Figure VIB). The Lgs binding mutant is not a potent
activator (G4DBD-S33Y-D164A) and the C-terminal domain deletion mutants (G4DBD-S33Y-
!C and G4DBD-S33Y-D164A-!C) cannot activate the reporter at all. Thus in mammalian
cells the C-terminus is more important for signalling then Lgs binding.
These results hint at a difference between mammals and Drosophila regarding the
contributions of the Lgs branch versus the C-terminal branch in Arm/!-catenin signalling. In
Drosophila cells the Lgs branch seems to be more important for signalling since the D164A
mutant is less active then the !C mutant. However, in mammalian tissue culture, the C-
terminal branch seems more important.
Table I. Rescue ability of arm transgenes
Transgene Rescue (%) n
None 0 150
Tub-Arm-wt 96 166
Tub-Arm-D164A 0 328
Tub-Arm-!C 4 356
Tub-Arm-D164A-!C 0 55
To investigate the relative inputs of the Lgs branch and the C-terminal branch of Arm
in the transcriptional activity in Drosophila in vivo the ability of different transgenes to rescue
arm null mutant animals (arm
2a9
) was analysed. Hemizygous arm
2a9
 males die as embryos.
With a tubulin"1-promoter-driven Arm-wt transgene these arm mutants can be rescued to
Females heterozygous for arm
2a9
 were crossed with males carrying different tubulin"1-
promoter-driven rescue constructs. The percentage of rescued males containing both the
arm
2a9
 allele and the tubulin"1 rescue construct are shown. n indicates the male progeny
that contain the tubulin"1 rescue construct but inherited the wild-type arm allele from the
balancer chromosome instead of the arm
2a9
 allele and therefore corresponds to the
expected number of arm
2a9
 males with the tubulin"1 rescue construct.
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adulthood without any obvious phenotypes. In contrast, arm
2a9
 males die as embryos or early
larvea when these Arm transgenes contain the D164A mutation or the combination of D164A-
!C. Surprisingly, an Arm-!C transgene also has some rescue activity, it can rescue
hemizygous arm
2a9
 males to adulthood without any obvious phenotypes but with a very low
efficiency (Table I). This suggests that in vivo in Drosophila the Lgs branch is more important
than the C-terminal branch for Wnt signalling. These results are consistent with the
Drosophila clone 8 cell experiments where the Lgs branch appeared to be more important
than the C-terminal branch.
To elucidate the functional importance of the two branches in a vertebrate model
organism, we started with the generation of embryonic stem (ES) cells where the endogenous
!-catenin protein (Figure VIIA) is replaced by a mutant one. Three different knock-in lines will
be created, containing either !-catenin-D164A, !-catenin-!C or the combined mutant !-
Figure VII: !-catenin genomic region and the targeting vectors
(A) The genomic region of mouse !-catenin. The exon are shown as blocks, the Arm repeats are indicated as
numbers (1-12) and N/C stands for the respective terminus.
(B) The !-catenin-D164A targeting vector. The 5' arm contains exon 2-4 and the 3' arm exon 5-8 and part of 9. In
exon 4 the amino acid D164 is changed to alanine.
(C) The !-catenin-!C targeting vector. The 5' arm contains exon 11-12 and the 3' arm exon 13 which is fused to
exon 15 (exon 14 is deleted). In exon 13 amino acid 673 is changed to a stop codon and is followed by a frame
shift.
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catenin-D164A-!C. These three different ES cell lines will be injected in blastocysts and mice
will be generated.
Two different targeting vectors were cloned both containing a 5' and 3' arm for
homologuos recombination and integration into the genomic DNA of ES cells. The !-catenin-
D164A vector (Figure VIIB) has a 5' arm where amino acid D164 is mutated to an alanine
(exon 4). This targeting vector also has a PGK-promoter-driven Hygromycin cassette flanked
by loxP sites for positive selection and a HSV-promoter-driven Thymidine Kinase cassette for
negative selection. The !-catenin-!C (Figure VIIC) vector has a 3' arm where part of exon 13
was fused to exon 15 creating a stop codon after amino acid 672 followed by a frame shift. In
case of read through, the frame shift will ensure a deletion of the C-terminus. Due to the
fusion of the exons, the stop codon is in the last exon of the gene and thus nonsense
mediated mRNA decay should not take place. In addition, this targeting vector has a PGK-
promoter-driven Neomycin cassette flanked by FRT sites for positive selection and a HSV-
promoter-driven Thymidine Kinase cassette for negative selection.
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3. Appendix
3.1 Constructs
Abbreviations:
aa amino acid
d Drosophila protein
h human protein
m mouse protein
m/h hybrid between mouse and human proteins
pRH1 pBTM116.2-BCL9 (aa 199-392)
pKX-BCL9 NcoI x XhoI ligated into pBTM116.2 NcoI x XhoI
pRH2 pBS-m!-cat (aa 129-421)
pRH3 pGAD424-hPygo2
pBTM116.2-hPygo2 EcoRI ligated into pGAD424 EcoRI
pRH5 pJP156-BCL9N (aa 1-732)
pGT-BCL9N NotI B. x XhoI ligated into pJP156 NcoI B. x SalI
pRH7 pGAD424-BCL9N (aa 1-732)
pGT-BCL9N NotI B. x XhoI ligated into pGAD424 BamHI B. x SalI
pRH8 pBTM116-m/h!-cat (aa 129-781) NotI not in frame
pGAD424-m/h!-cat (aa 129-781) BamHI x SalI ligated into pBTM116 BamHI x SalI
pRH9 pBS-m/h!-cat (aa 129-781) NotI not in frame
pGAD424-m/h!-cat (aa 129-781) SmaI x SalI ligated into pBS SmaI x SalI
pRH10 pK378-m/h!-cat (aa 129-781) NotI not in frame
pRH9 XbaI x SalI ligated into pK378 XbaI x SalI
pRH11 pK378-m/h!-cat (aa 129-781) NotI in frame
pGAD424-m/h!-cat (aa 129-781) BamHI B. x SalI ligated into pK378 BamHI B. x XhoI
pRH14 pGAD424.1-hTcf4 (aa 1-130) contain Q27R
pET-hTcf4 (aa 1-130) BamHI x XhoI ligated into pGAD424.1 BamHI x SalI
pRH15 pBTM116RI-hTcf4 (aa 1-130) contain Q27R
pRH14 EcoRI x PstI ligated into pBTM116 EcoRI x PstI
pRH17 pBTM116RI-m/h!-cat (aa 129-781)
pGAD424.1-m/h!-cat (aa 129-781) BamHI x SalI B. ligated into pRH14 BamHI x PstI B.
pRH18 pJP156-m/h!-cat (aa 129-781)
pRH9 XbaI x XhoI ligated into pJP156 XbaI x SalI
pRH19 pBTM116-"-cat Not OK
p29 XbaI B. x EcoRV ligated into pBTM116 SmaI
pRH21 pBTM116.2-Lgs (HD2)
Lgs? NcoI x NotI ligated into pBTM116.2 NcoI x NotI
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pRH22 pGAD424-Hkb
Hkb? EcoRI x XhoI ligated into pAGD424 EcoRI x SalI
pRH23 pBTM116RI-m/h!-cat !C (aa 129-662)
pRH24 BamHI x BglII B. ligated into pRH15 BamHI x PstI B.
pRH24 pGAD424.1-m/h!-cat WT-R !C (aa 129-662)
pGAD424.1-ß-cat WT-R (aa 129-781) NdeI B. x SalI B. religated
pRH25 pK378-m/h!-cat !C (aa 129-662)
pRH11 ApaI B. x NdeI B. religated (129-662)
pRH26 pBS-m/h!-cat !C (aa 129-662)
pRH9 NdeI B. x Sal I B. religated
pRH27 pBTM116-BCL9N
pRH7 SmaI x BglII ligated into pBTM116 SmaI x BamHI
pRH28 pJP156-m/h!-cat !C (aa 129-662)
pRH26 XbaI x XhoI ligated into pJP156 XbaI x SalI
pRH29 pBridgeMII-hTcf4 (aa 1-130)-ß-cat (aa 129-662) not yet sequenced
pRH25 NotI ligated into pRH33 NotI
pRH30 pCATCH-m/h!-cat WT-R (aa 129-781)
pGAD424.1-ß-cat WT-R BamHI x SalI ligated into pCATCH BamHI x XhoI
pRH31 pCATCH-m/h!-cat D162A (aa 129-781)
pGAD424.1-ß-cat D162A BamHI x SalI ligated into pCATCH BamHI x XhoI
pRH32 pCATCH-m/h!-cat D164A (aa 129-781)
pGAD424.1-ß-cat D164A BamHI x SalI ligated into pCATCH BamHI x XhoI
pRH33 pBridgeMII-hTcf4 (aa 1-130)
pRH15 HindIII ligated into pBridge HindIII
pRH34 pGAD424.1-mPygo2 (PHD)
pGEX-mPygo2 (PHD) BamHI x XhoI B. ligated into pRH14 BamHI x PstI B.
pRH35 pKB342-Arm
S10
pBS-Arm
S10
 NotI B. x Asp718 ligated into pKB342 EcoRV x Asp718
pRH36 pKB342-Arm
S10
 E171A
mutation made in pRH35
pRH37 pKB342-Arm
S10
 D172A
mutation made in pRH35
pRH38 pKB342-Arm
S10
 A303W/ I304W
mutation made in pRH35
pRH39 pKB342-Arm
S10 
K443E
mutation made in pRH35
pRH40 pGAD424-m/h!-cat 3-C "WT" (aa 129-781) not in frame
Cut out BamHI/SalI
pRH41 pGAD424-m/h!-cat 3-C WT-R (aa 129-781) not in frame
Cut out BamHI/SalI
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pRH42 pGAD424-m/h!-cat H260A (aa 129-781) not in frame
Cut out BamHI/SalI
pRH43 pGAD424-m/h!-cat K270A (aa 129-781) not in frame
Cut out BamHI/SalI
pRH44 pGAD424-m/h!-cat R274A (aa 129-781) not in frame
Cut out BamHI/SalI
pRH45 pGAD424-m/h!-cat K292A (aa 129-781) not in frame
Cut out BamHI/SalI
pRH46 pGAD424-m/h!-cat R342A (aa 129-781) not in frame
Cut out BamHI/SalI
pRH47 pGAD424-m/h!-cat K345A (aa 129-781) not in frame
Cut out BamHI/SalI
pRH48 pGAD424-m/h!-cat K354A (aa 129-781) not in frame
Cut out BamHI/SalI
pRH49 pGAD424-m/h!-cat R376A (aa 129-781) not in frame
Cut out BamHI/SalI
pRH50 pGAD424-m/h!-cat W383A (aa 129-781) not in frame
Cut out BamHI/SalI
pRH51 pGAD424-m/h!-cat R386A (aa 129-781) not in frame
Cut out BamHI/SalI
pRH52 pGAD424-m/h!-cat R386A (aa 129-781) not in frame
Cut out BamHI/SalI
pRH53 pGAD424-m/h!-cat K394A (aa 129-781) not in frame
Cut out BamHI/SalI
pRH54 pGAD424.1-m/h!-cat WT (aa 129-781)
Cut out BamHI/SalI
pRH55 pGAD424.1-m/h!-cat WT-R (aa 129-781)
Cut out BamHI/SalI
pRH56 pGAD424.1-m/h!-cat R151A (aa 129-781)
Cut out BamHI/SalI
pRH57 pGAD424.1-m/h!-cat K158A (aa 129-781)
Cut out BamHI/SalI
pRH58 pGAD424.1-m/h!-cat D162A (aa 129-781)
Cut out BamHI/SalI
pRH59 pGAD424.1-m/h!-cat E163A (aa 129-781)
Cut out BamHI/SalI
pRH60 pGAD424.1-m/h!-cat D164A (aa 129-781)
Cut out BamHI/SalI
pRH61 pGAD424.1-m/h!-cat K170A (aa 129-781)
Cut out BamHI/SalI
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pRH62 pGAD424.1-m/h!-cat K180A (aa 129-781)
Cut out BamHI/SalI
pRH63 pGAD424.1-m/h!-cat K181A (aa 129-781)
Cut out BamHI/SalI
pRH64 pGAD424.1-m/h!-cat R190A (aa 129-781)
Cut out BamHI/SalI
pRH65 pGAD424.1-m/h!-cat R200A (aa 129-781)
Cut out BamHI/SalI
pRH66 pGAD424.1-m/h!-cat R212A (aa 129-781)
Cut out BamHI/SalI
pRH67 pGAD424.1-m/h!-cat H223A (aa 129-781)
Cut out BamHI/SalI
pRH68 pGAD424.1-m/h!-cat R225A (aa 129-781)
Cut out BamHI/SalI
pRH69 pGAD424.1-m/h!-cat F253A (aa 129-781)
Cut out BamHI/SalI
pRH70 pGAD424.1-m/h!-cat T257A (aa 129-781)
Cut out BamHI/SalI
pRH71 pGAD424.1-m/h!-cat H260A (aa 129-781)
Cut out BamHI/SalI
pRH72 pGAD424.1-m/h!-cat K270A (aa 129-781)
Cut out BamHI/SalI
pRH73 pGAD424.1-m/h!-cat R274A (aa 129-781)
Cut out BamHI/SalI
pRH74 pGAD424.1-m/h!-cat K292A (aa 129-781)
Cut out BamHI/SalI
pRH75 pGAD424.1-m/h!-cat F293A (aa 129-781)
Cut out BamHI/SalI
pRH76 pGAD424.1-m/h!-cat I296A (aa 129-781)
Cut out BamHI/SalI
pRH77 pGAD424.1-m/h!-cat W338A (aa 129-781)
Cut out BamHI/SalI
pRH78 pGAD424.1-m/h!-cat R342A (aa 129-781)
Cut out BamHI/SalI
pRH79 pGAD424.1-m/h!-cat K345 (aa 129-781)
Cut out BamHI/SalI
pRH80 pGAD424.1-m/h!-cat K354A (aa 129-781)
Cut out BamHI/SalI
pRH81 pGAD424.1-m/h!-cat R376A (aa 129-781)
Cut out BamHI/SalI
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pRH82 pGAD424.1-m/h!-cat W383A (aa 129-781)
Cut out BamHI/SalI
pRH83 pGAD424.1-m/h!-cat R386A (aa 129-781)
Cut out BamHI/SalI
pRH84 pGAD424.1-m/h!-cat K394A (aa 129-781)
Cut out BamHI/SalI
pRH85 pGAD424.1-m/h!-cat N426A (aa 129-781)
Cut out BamHI/SalI
pRH86 pGAD424.1-m/h!-cat L427E (aa 129-781)
Cut out BamHI/SalI
pRH87 pGAD424.1-m/h!-cat N430A (aa 129-781)
Cut out BamHI/SalI
pRH88 pGAD424.1-m/h!-cat K435A (aa 129-781)
Cut out BamHI/SalI
pRH89 pGAD424.1-m/h!-cat R457A (aa 129-781)
Cut out BamHI/SalI
pRH90 pGAD424.1-m/h!-cat E462A (aa 129-781)
Cut out BamHI/SalI
pRH91 pGAD424.1-m/h!-cat R469A (aa 129-781)
Cut out BamHI/SalI
pRH92 pGAD424.1-m/h!-cat H470A (aa 129-781)
Cut out BamHI/SalI
pRH93 pGAD424.1-m/h!-cat W504A (aa 129-781)
Cut out BamHI/SalI
pRH94 pGAD424.1-m/h!-cat N516A (aa 129-781)
Cut out BamHI/SalI
pRH95 pGAD424.1-m/h!-cat WT-R (aa 1-781)
p30 BamHI x PmlI ligated into pRH55 BamHI x PmlI, can be cut out BamHI/SalI
pRH96 pGAD424.1-m/h!-cat K158A (aa 1-781)
p30 BamHI x PmlI ligated into pRH57 BamHI x PmlI, can be cut out BamHI/SalI
pRH97 pGAD424.1-m/h!-cat D162A (aa 1-781)
p30 BamHI x PmlI ligated into pRH58 BamHI x PmlI, can be cut out BamHI/SalI
pRH98 pGAD424.1-m/h!-cat E163A (aa 1-781)
p30 BamHI x PmlI ligated into pRH59 BamHI x PmlI, can be cut out BamHI/SalI
pRH99 pGAD424.1-m/h!-cat D164A (aa 1-781)
p30 BamHI x PmlI ligated into pRH60 BamHI x PmlI, can be cut out BamHI/SalI
PRH100 pBTM116.2-dE-APC
dE-APC EcoRI x SalI ligated into pBTM116.2 EcoRI x XhoI
pRH101 pBTM116-Pan (aa 1-129)
pTK-Pan EcoRI ligated into pBTM116 EcoRI
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pRH102 pGAD424-Arm(myc)-wt (aa 38-806)
p39 EcoRI x NcoI blunt ligated into pGAD424 BamHI blunt
pRH103 pGAD424-Arm(myc)-E171A (aa 38-806)
p40 EcoRI x NcoI blunt ligated into pGAD424 BamHI blunt
pRH104 pGAD424-Arm(myc)-D172A (aa 38-806)
p41 EcoRI x NcoI blunt ligated into pGAD424 BamHI blunt
pRH105 pGAD424-Arm(myc)-A303W/I304W (aa 38-806)
p42 EcoRI x NcoI blunt ligated into pGAD424 BamHI blunt
pRH106 pGAD424-Arm(myc)-K443E (aa 38-806)
p43 EcoRI x NcoI blunt ligated into pGAD424 BamHI blunt
pRH107 pGAD424-hPlakoglobin
p66 EcoRI blunt ligated into pGAD424 SmaI
pRH108 pCATCH-m/h!-cat-S33Y-wt (aa 1-781)
pGAD424-S33Y-wt BamHI x SalI ligated into pCATCH BamHI x XhoI
pRH109 pCATCH-m/h!-cat-S33Y-E163A (aa 1-781)
pGAD424-S33Y-E171A BamHI x SalI ligated into pCATCH BamHI x XhoI
pRH110 pCATCH-m/h!-cat-S33Y-D164A (aa 1-781)
pGAD424-S33Y-D172A BamHI x SalI ligated into pCATCH BamHI x XhoI
pRH111 pcDNA3-CD2-m/h!-cat-S33Y-wt 
pGAD424-S33Y-wt BamHI x SalI ligated into pOP238 BamHI x XhoI
pRH112 pcDNA3-CD2-m/h!-cat-S33Y-E163A 
pGAD424-S33Y-E163A BamHI x SalI ligated into pOP238 BamHI x XhoI
pRH113 pcDNA3-CD2-m/h!-cat-S33Y-D164A
pGAD424-S33Y-D164A BamHI x SalI ligated into pOP238 BamHI x XhoI
pRH114 pcDNA3.1-KOZAK-m/h!-cat-S33Y-wt
PCR on pRH108 with mb-cat Asp718 and hb-cat XbaI ligated into pcDNA3.1 Asp718 x XbaI
pRH115 pcDNA3.1-KOZAK-m/h!-cat-S33Y-E163A
PCR on pRH109 with mb-cat Asp718 and hb-cat XbaI ligated into pcDNA3.1 Asp718 x XbaI
pRH116 pcDNA3.1-KOZAK-m/h!-cat-S33Y-D164A
PCR on pRH110 with mb-cat Asp718 and hb-cat XbaI ligated into pcDNA3.1 Asp718 x XbaI
pRH117 pcDNA3.1-KOZAK-m/h!-cat
PCR on pRH95 with mb-cat Asp718 and hb-cat XbaI ligated into pcDNA3.1 Asp718 x XbaI
pRH118 pUAST-CD2-m/h!-cat-S33Y-wt
pRH111 ApaI blunt x Asp718 ligated into pUAST XbaI blunt x Asp718
pRH119 pUAST-m/h!-cat-S33Y-wt
pRH114 Asp718 x XbaI ligated into pUAST Asp718 x XbaI
pRH120 pPGS-CMV-CITE-neo-h!-cat-S33Y-D164A
PCR on p59 with hbcat D164Af and D164Ar XhoI x EcoRI ligated into p59 XhoI x EcoRI
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pRH121 pcDNA3.1B-V5-HIS-Lef1
pCR on p54 with m.m.Lef XbaI and m.m.Lef EcoRI ligated into pcDNA3.1B-V5-HIS XbaI x
EcoRI
pRH122 pGAD424-Arm-F261D/F301D (aa 38-806)
pKB384-Arm-F261D/F301D DraIII x BssHII ligated into pRH102 DraIII x BssHII
pRH123 pBTM116.2-dEcad (aa 1346-1508) auto activates
PCR on T289 fly DNA with dE-cad (EcoRI) and SV40 rev, TOPO cloned, EcoRI x NotI ligated
into pBTM116.2 EcoRI x NotI
pRH124 pPGS-CMV-CITE-neo-h!-cat-S33Y-E163A
PCR on p59 with hbcat E163Af and E163Ar XhoI x EcoRI ligated into p59 XhoI x EcoRI
pRH125 pBTM116-m"-cat (aa 1-750)
p16 EcoRV x BamHI ligated into pBTM116 SmaI x BamHI
pRH126 pBS-d"-cat (aa 1-394)
PCR on EST d"-cat with d"-cat EcoRI and d"-cat SalI ligated into pBS EcoRI x SalI
pRH127 pPGS-CITE-m/h!-cat-S33Y
pRH114 Asp718 x XbaI blunt ligated into pPGS-CITE+ EcoRI blunt
pRH128 pPGS-CMV-m/h!-cat-S33Y
pRH114 Asp718 x XbaI blunt ligated into pPGS-CMV+ EcoRI blunt
pRH129 pPGS-CMV-FLAG+
FLAG BamHI & NotI oligo ligated into pPGS-CMV+ BamHI x NotI
pRH130 pUAST-m/h!-cat-S33Y-D164A
pRH16 Asp718 x XbaI ligated into pUAST Asp718 x XbaI
pRH131 pPGS-CITE-CD2-m/h!-cat-S33Y
pRH111 Asp718 x ApaI blunt ligated into pPGS-CITE+ EcoRI blunt
pRH132 pcDNA3.1-KOZAK-m/h!-cat-S33Y-D162A/D164A
Quicksite mutagenesis PCR on pRH116 to introduce D162A using D162A f mbcatD164A and
D162A r mbcatD164A, can be cut out with Asp718 x XbaI
pRH133 pAc5.1/V5-HIS-B-KOZAK-m/h!-cat-
pRH117 Asp718 x XbaI ligated into pRE147 Asp718 x XbaI
pRH134 pcDNA3.1-Gal4-DNA-BD
pRE145 Asp718 x BglII ligated into pcDNA3.1 Asp718 x BamHI
pRH135 pAc5.1/V5-HIS-B-KOZAK-m/h!-cat-D164A
Quicksite mutagenesis PCR on pRH133 with mbcat D164Af/r to introduce D164A
PRH136 pGAD424.1-m/h!-cat-R386A (aa 1-781)
Quicksite mutagenesis PCR on pRH95 with hbcat R386Af/r, can be cut out with BamHI x SalI
pRH137 pGAD424.1-m/h!-cat-Y142A (aa 1-781)
Quicksite mutagenesis PCR on pRH95 with mbcat Y142Af/r, can be cut out with BamHI x SalI
pRH138 pMT-KOZAK-m/h!-cat
pRH133 Asp718 x XbaI ligated into pMT/V5-HIS-B Asp718 x XbaI
pRH139 pMT-KOZAK-m/h!-cat-D164A
pRH135 Asp718 x XbaI ligated into pMT/V5-HIS-B Asp718 x XbaI
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pRH140 pAc-Gal4BD-ArmR1-4-D172A (aa 156-356)PCR f ArmR1-4S and r ArmR1-4
on p47, cut BglII x BssHII + pRE170 Asp718 x BglII ligated (3-way) into pRE149 Asp718 x
BglII
pRH141 pGAD424.1-m/h!-cat-Y142D (aa 1-781)
Quicksite mutagenesis on pRH95 with mbcat Y142Df/r, can be cut out with BamHI x SalI
pRH142 pAc-Gal4BD-!N-Arm (aa 156-843)
PCR on p45 with f ArmR1-4S and Arm MluI cut with BglII x MluI ligated into pAc-Gal4BD BglII
x BssHII
pRH143 pGAD424(MCS pRE192)
oligo MCS pRE192 ligated into pGAD424 EcoRI x PstI
pRH144 pCR2.1-mWnt3a
PCR on p75 with mWnt3a f and mWnt3a r, TOPO cloned
pRH145 pGAD424.1-m/h!-cat-Y142E
Quicksite mutagenesis on pRH95 to introduce Y142E, can be cut out with BamHI x SalI
pRH146 pcDNA3.1-mWnt3a
pRH144 HindIII x EcoRI ligated into pcDNA3.1 HindIII x EcoRI
pRH147 pcDNA3.1-mWnt3a-V5
pRH144 HindIII x XbaI ligated into pcDNA3.1/V5 HindIII x XbaI
pRH148 pCR2.1-hLgs2
PCR on p79 with hLgs2 HD1+2f and hLgs2 HD1+2r, TOPO cloned
pRH149 pBTM116-hLgs2 (HD1+2)
pRH148 EcoRI x NotI ligated into pRE192 EcoRI x NotI
pRH150 pBS-hP300-CH3 (aa 1641-1956) (pointmutation T1924A)
PCR on p78 with hP300 CH3f and hP300 CH3r, cut with BamHI x NotI ligated into pBS
BamHI x NotI
pRH151 pCR2.1-m!-cat (aa 130-781)
PCR on p30 with Bam mß-cat and BGH rev, TOPO cloned
pRH152 pCR2.1-m!-cat-Y654A (aa 130-781)
Quicksite mutagenesis on pRH151 with mbcat Y654Af/r, can be cut out with BamHI
pRH153 pCR2.1-m!-cat-F660A (aa 130-781)
Quicksite mutagenesis on pRH151 with mbcat F660Af/r, can be cut out with BamHI
pRH154 pCR2.1-m!-cat-R661A (aa 130-781)
Quicksite mutagenesis on pRH151 with mbcat R661Af/r, can be cut out with BamHI
pRH155 pCR2.1-m!-cat-E664A (aa 130-781)
Quicksite mutagenesis on pRH151 with mbcat E664Af/r, can be cut out with BamHI
pRH156 pcDNA3.1-NLS/V5-His
Oligo NLS ligated into pcDNA3.1/V5-His Asp718 x BamHI
pRH157 pGAD424-m!-cat-wt (aa 130-781)
pRH151 BamHI ligated into pRH143 BamHI
pRH158 pGAD424-m!-cat-Y654A (aa 130-781)
pRH152 BamHI ligated into pRH143 BamHI
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pRH159 pGAD424-m!-cat-F660A (aa 130-781)
pRH153 BamHI ligated into pRH143 BamHI
pRH160 pGAD424-m!-cat-R661A (aa 130-781)
pRH154 BamHI ligated into pRH143 BamHI
pRH161 pGAD424-m!-cat-E664A (aa 130-781)
pRH155 BamHI ligated into pRH143 BamHI
pRH162 pBTM116-hP300-CH3 (aa 1641-1959)
pRH150 BamHI x NotI ligated into pRE192 BamHI x NotI
pRH163 pcDNA3.1/V5-mWnt3a (no V5 tag)
pRH144 HindIII x EcoRI ligated into pcDNA3.1/V5-His HindIII x EcoRI
pRH164 pBTM116-mCBP (1-188) auto activates
p76 BamHI x ApaI blunt ligated into pRE192 BamHI x PstI blunt
pRH165 pBTM116-mCBP (1-359) auto activates
p76 BamHI x EcoRV ligated into pRE192 BamHI x PstI blunt
pRH166 pcDNA3.1-Gal4-m!-cat-wt (aa 130-781) stop between Gal4&mß-cat
pRH157 BamHI blunt ligated into pRH134 EcoRI blunt
pRH167 pcDNA3.1-Gal4-m!-cat-Y654A (aa 130-781) stop between Gal4&mß-cat
pRH158 BamHI blunt ligated into pRH134 EcoRI blunt
pRH168 pcDNA3.1-Gal4-m!-cat-F660A (aa 130-781) stop between Gal4&mß-cat
pRH159 BamHI blunt ligated into pRH134 EcoRI blunt
pRH169 pcDNA3.1-Gal4-m!-cat-R661A (aa 130-781) stop between Gal4&mß-cat
pRH160 BamHI blunt ligated into pRH134 EcoRI blunt
pRH170 pcDNA3.1-Gal4-m!-cat-E664A (aa 130-781) stop between Gal4&mß-cat
pRH161 BamHI blunt ligated into pRH134 EcoRI blunt
pRH171 pcDNA3.1-Gal4BD.2
PCR on pRH134 with Gal4BD Asp718 f and Gal4BD BamHI r ligated into pcDNA3.1 Asp718
x BamHI
pRH172 pBS-m!-cat-!C (aa 1-673)
PCR on p30 with mbcat!C NotI and Bam f mbcat ligated into pBS BamHI x Not
pRH173 pcDNA3.1-myc
Oligo Asp718 myc BamHI ligated into pcDNA3.1 Asp718 x BamHI
pRH174 pBTM116-m!-cat (aa 536-781) auto activates
pRH157 SpeI blunt x SalI ligated into pBTM116 BamHI blunt x SalI
pRH175 pcDNA3.1-Gal4BD.2-!N-m!-cat-wt (aa 130-781)
pRH157  BamHI x SmaI ligated into pRH171 BamHI x EcoRV
pRH176 pcDNA3.1-Gal4BD.2-!N-m!-cat-Y654A (aa 130-781)
pRH158  BamHI x SmaI ligated into pRH171 BamHI x EcoRV
pRH177 pcDNA3.1-Gal4BD.2-!N-m!-cat-F660A (aa 130-781)
pRH159  BamHI x SmaI ligated into pRH171 BamHI x EcoRV
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pRH178 pcDNA3.1-Gal4BD.2-!N-m!-cat-R661A (aa 130-781)
pRH160  BamHI x SmaI ligated into pRH171 BamHI x EcoRV
pRH179 pcDNA3.1-Gal4BD.2-!N-m!-cat-E664A (aa 130-781)
pRH161  BamHI x SmaI ligated into pRH171 BamHI x EcoRV
pRH180 pcDNA3.1-myc-!N-m!-cat-wt (aa 130-781)
pRH157  BamHI x SmaI ligated into pRH173 BamHI x EcoRV
pRH181 pcDNA3.1-myc-!N-m!-cat-Y654A (aa 130-781)
pRH158  BamHI x SmaI ligated into pRH173 BamHI x EcoRV
pRH182 pcDNA3.1-myc-!N-m!-cat-F660A (aa 130-781)
pRH159  BamHI x SmaI ligated into pRH173 BamHI x EcoRV
pRH183 pcDNA3.1-myc-!N-m!-cat-R661A (aa 130-781)
pRH160  BamHI x SmaI ligated into pRH173 BamHI x EcoRV
pRH184 pcDNA3.1-myc-!N-m!-cat-E664A (aa 130-781)
pRH161  BamHI x SmaI ligated into pRH173 BamHI x EcoRV
pRH185 pcDNA3.1-GAL4BD.2-!N-m!-cat-D164A (aa 130-781)
Quicksite mutagenesis on pRH175 with mbcat D164Af/r, can be cut out with BamHI x XbaI
pRH186 pBS-Arm(myc) (contains tub-trailer)
p45 Asp718 x XbaI ligated into pBS Asp718 x XbaI
pRH187 pBS-Arm
S10
 (myc) (contains tub-trailer)
pDA720 Asp718 x XbaI ligated into pBS Asp718 x XbaI
pRH188 pcDNA3-NLS-HA-dLgs!HD1
pTK98 AgeI x XhoI ligated into pOP244 AgeI x XhoI
pRH189 pcDNA3.1-NLS-m!-cat-!C-V5/His (aa 1-673)
pRH172 BamHI x NotI ligated into pRH156 BamHI x NotI
pRH190 pMZ55-mCBP (aa 1-270)
pRH165 Asp718 blunt x BamHI ligated into pMZ55 HindIII blunt x BamHI
pRH191 ptub-Arm(myc)-Y150A
Quicksite mutagenesis on pRH186 with Arm Y150Af1/r1, cut Asp718 x XbaI ligated into
pOP118 Asp718 x XbaI
pRH192 pUAST-Arm
S10
 (myc)-Y150A
Quicksite mutagenesis on pRH187 with Arm Y150Af1/r1, cut Asp718 x XbaI ligated into
pUAST Asp718 x XbaI
pRH193 pcDNA3.1-GAL4BD.2-!N-m!-cat-F660A/E664A (aa 130-781)
Quicksite mutagenesis on pRH179 with mbcat F660A on E664Af/r, cut BamHI x XbaI ligated
into pRH171 BamHI x XbaI
pRH194 pcDNA3.1-GAL4BD.2-m!-cat-S33Y-wt (aa 1-781)
pRH111 BamHI x BbrPI ligated into pRH175 BamHI x BbrPI
pRH195 pcDNA3.1-GAL4BD.2-m!-cat-S33Y-Y654A (aa 1-781)
pRH111 BamHI x BbrPI ligated into pRH176 BamHI x BbrPI
pRH196 pcDNA3.1-GAL4BD.2-m!-cat-S33Y-F660A (aa 1-781)
pRH111 BamHI x BbrPI ligated into pRH177 BamHI x BbrPI
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pRH197 pcDNA3.1-GAL4BD.2-m!-cat-S33Y-R661A (aa 1-781)
pRH111 BamHI x BbrPI ligated into pRH178 BamHI x BbrPI
pRH198 pcDNA3.1-GAL4BD.2-m!-cat-S33Y-E664A (aa 1-781)
pRH111 BamHI x BbrPI ligated into pRH179 BamHI x BbrPI
pRH199 pcDNA3.1-GAL4BD.2-m!-cat-S33Y-D164A (aa 1-781)
pRH111 BamHI x BbrPI ligated into pRH185 BamHI x BbrPI
pRH200 ptub-NLS-HA-dLgs
pOP244 Asp718 x XbaI ligated into pOP118 Asp718 x XbaI
pRH201 ptub-NLS-HA-dLgs!HD1
pRH188 Asp718 x XbaI ligated into pOP118 Asp718 x XbaI
pRH202 pBS-NLS-HA-tub trailer
Oligo Asp718 NLS BssHII ligated into pMZ55 Asp718 NLS BssHII
pRH203 pcDNA3.1-HA-mCBP (aa 1-270)
pRH190 Asp718 x XbaI ligated into pcDNA3.1 Asp718 x XbaI
pRH204 pBS-NLS-HA-BCL9N!HD1 (aa 1-732)
PCR with BglII K. BCL9 and BCL9 732 S. NheI on pTK118 cut with BglII x NotI ligated into
pRH202 BamHI x NotI
pRH205 pcDNA3.1-GAL4BD.2-m!-cat-S33Y-Y142A
pRH137 BbrPI x BsmBI ligated into pRH194 BbrPI x BsmBI
pRH206 pBS-NLS-HA-BCL9N (aa 1-732)
PCR with BglII K. BCL9 and BCL9 732 S. NheI on p55 cut with BglII x NotI ligated into
pRH202 BamHI x NotI
pRH207 pcDNA3.1-GAL4DBD.2-m!-cat-R8-C-wt (aa 410-781)
Oligo BamHI BstEII ligated into pRH175 BamHI x BstEII
pRH208 pcDNA3.1-GAL4BD.2-m!-cat-S33Y-Y142E
pRH145 BbrPI x BsmBI ligated into pRH194 BbrPI x BsmBI
pRH209 pPacPL-NLS-HA-BCL9N!HD1 (aa 1-732)
pRH204 cut with Asp718 x NotI ligated into pRE398 Asp718 x NotI
pRH210 pcDNA3.1-NLS-HA-BCL9N!HD1 (aa 1-732)
pRH204 cut with Asp718 x NotI ligated into pcDNA3.1 Asp718 x NotI
pRH211 pcDNA3.1-NLS-HA-BCL9N (aa 1-732)
pRH206 cut with Asp718 x NotI ligated into pcDNA3.1 Asp718 x NotI
pRH212 pPacPL-NLS-HA-BCL9N (aa 1-732)
pRH206 cut with Asp718 x NotI ligated into pRE398 Asp718 x NotI
pRH213 pcDNA3.1-GAL4BD.2-m!-cat-S33Y-Y142D
pRH141 BbrPI x BsmBI ligated into pRH194 BbrPI x BsmBI
pRH214 pDU10-Ire1!TM (aa 555-1115)
pDU62 cut with NotI x SalI ligated into pDU10 NotI x SalI
pRH215 pDU12-Ire1!TM (aa 555-1115)
pDU62 cut with NotI x SalI ligated into pDU12 NotI x SalI
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pRH216 pBS-mCBP (aa 1-270)
PCR on pRH203 with mCBP 316 NotI r and mCBP XbaI f, cut with XbaI x NotI ligated into
pBS XbaI x NotI
pRH217 pBS-BCL9 (aa 199-392)
PCR on p55 with BCL9 199 Xba f and BCL9 392 Not r, cut with XbaI x NotI ligated into pBS
XbaI x NotI
pRH218 pGEX-KG-!N-mß-cat (aa 130-781)
pRH175 BamHI x XbaI ligated into pGEX-KG BamHI x XbaI
pRH219 pBS-hTCF4 (aa 1-130)
PCR on pRH14 with hTCF4 Xba f and hTCF4 Not r, cut with XbaI x NotI ligated into pBS XbaI
x NotI
pRH220 ptub-NLS-HA-LgsN (1-768)
pMZ55 BamHI x XbaI ligated into pRH200 BglII x XbaI
pRH221 pcDNA3.1-GAL4DBD.2-m!-cat-R8-C-Y654A (aa 410-781)
pRH176 BstEII x XbaI ligated into pRH207 BstEII x XbaI
pRH222 pcDNA3.1-GAL4DBD.2-m!-cat-R8-C-F660A (aa 410-781)
pRH177 BstEII x XbaI ligated into pRH207 BstEII x XbaI
pRH223 pcDNA3.1-GAL4DBD.2-m!-cat-R8-C-R661A (aa 410-781)
pRH178 BstEII x XbaI ligated into pRH207 BstEII x XbaI
pRH224 pcDNA3.1-GAL4DBD.2-m!-cat-R8-C-E664A (aa 410-781)
pRH179 BstEII x XbaI ligated into pRH207 BstEII x XbaI
pRH225 pDU10-Ire1!TM-mCBP (aa 1-270)
pRH216 XbaI x NotI ligated into pRH214 XbaI x NotI
pRH226 pDU10-Ire1!TM-BCL9 (aa 199-392)
pRH217 XbaI x NotI ligated into pRH214 XbaI x NotI
pRH227 pPacPL-HA-BCL9N (aa 1-732)
Oligo Asp718 ATG BssHII ligated into pRH212 Asp718 x BssHII
pRH228 pPacPL-HA-BCL9N!HD1 (aa 1-732)
Oligo Asp718 ATG BssHII ligated into pRH209 Asp718 x BssHII
pRH229 pDU10-Ire1!TM-hTCF4 (aa 1-130)
pRH219 XbaI x NotI ligated into pRH214 XbaI x NotI
pRH230 ptub-NLS-HA-LgsN-!HD1 (aa 1-768)
pRH201 BamHI ligated into pRH220 BamHI
pRH231 pcDNA3.1-HA (wg leader-HA)
pMZ55 Asp718 x BamHI ligated into pcDNA3.1 Asp718 x BamHI
pRH232 pPacPL-Arm-HA-NLS
pRH186 Asp718 x ApaI ligated into pRE367 Asp718 x ApaI
pRH233 pcDNA3.1-GAL4BD.2-m!-cat-S33Y-D164A/Y654A (aa 1-781)
pRH199 SpeI ligated into pRH221 SpeI
pRH234 pcDNA3.1-HA-hICAT
pGEX-4T-3-hICAT BamHI x EcoRI ligated into pRH231 BamHI x EcoRI
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pRH235 pcDNA3.1-HA-hP300-CH3 (1710-1891)
pGEX-4T-1-hP300-CH3 BamHI x NotI ligated into pRH231 BamHI x NotI
pRH236 ptub-LgsN (aa 1-768)
pMZ55 BamHI x XbaI ligated into pOP212 BglII x XbaI
pRH237 pcDNA3.1-GAL4DBD.2-m!-cat-R8-C-Y654E (aa 410-781)
Quicksite mutagenesis on pRH207 with mbcat Y654Ef/r, can be cut out with BamHI x XbaI
pRH238 pcDNA3.1-GAL4DBD.2-m!-cat-R8-C-F660A/R661A (aa 410-781)
Quicksite mutagenesis on pRH222 with mbcat R661A on F660Af/r, can be cut out with
BamHI x XbaI
pRH239 pcDNA3.1-NLS-HA-LgsN (aa 1-768)
pRH220 Asp718 x XbaI ligated into pcDNA3.1 Asp718 x XbaI
pRH240 pcDNA3.1-NLS-HA-LgsN!HD1 (aa 1-768)
pRH230 Asp718 x XbaI ligated into pcDNA3.1 Asp718 x XbaI
pRH241 pBTM116-hICAT
pGEX-4T-3-hICAT BamHI x NotI ligated into pRE192 BamHI x NotI
pRH242 pBTM116-hP300-CH3 (aa 1710-1891)
pGEX-4T-1-hP300-CH3 BamHI x NotI ligated into pRE192 BamHI x NotI
pRH243 pcDNA3.1-NLS-Arm
pRH232 Asp718 x XbaI ligated into pcDNA3.1 Asp718 x XbaI
pRH244 pcDNA3.1-HA-LgsN (aa 1-768)
pOP221 Asp718 x PinAI ligated into pRH239 Asp718 x PinAI
pRH245 pcDNA3.1-HA-LgsN!HD1 (aa 1-768)
pOP221 Asp718 x PinAI ligated into pRH240 Asp718 x PinAI
pRH246 pGAD424-m/h!-cat-N-R5-wt (aa 1–356)
pRH95 NgoMIV blunt x Sal I blunt, religated
pRH247 pGAD424-m/h!-cat-N-R5-Y142A (aa 1–356)
pRH137 NgoMIV blunt x Sal I blunt, religated
pRH248 pGAD424-m/h!-cat-N-R5-D164A (aa 1–356)
pRH99 NgoMIV blunt x Sal I blunt, religated
pRH249 pcDNA3-CD2-m!-cat-S33Y-Y142A
pRH205 BamHI x NotI ligated into pOP238 BamHI x NotI
pRH250 pBS-hPygo2-!74-78
pRE201 BglII x BssHII ligated into pRE344 BglII x BssHII
pRH251 pBS-hPygo2-!Thomas
pRE202 BglII x BssHII ligated into pRE344 BglII x BssHII
pRH252 ptub-HA-LgsN (aa 1-768)
pRH244 Asp718 x XbaI ligated into pOP118 Asp718 x XbaI
pRH253 ptub-HA-LgsN!HD1 (aa 1-768)
pRH245 Asp718 x XbaI ligated into pOP118 Asp718 x XbaI
pRH254 pcDNA3.1-HA-m!-cat-wt (aa 410-781)
pRH207 BamHI x NotI ligated into pRH231 BamHI x NotI
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pRH255 pcDNA3.1-HA-m!-cat-Y654A (aa 410-781)
pRH221 BamHI x NotI ligated into pRH231 BamHI x NotI
pRH256 pcDNA3.1-HA-m!-cat-F660A (aa 410-781)
pRH222 BamHI x NotI ligated into pRH231 BamHI x NotI
pRH257 pcDNA3.1-HA-m!-cat-R661A (aa 410-781)
pRH223 BamHI x NotI ligated into pRH231 BamHI x NotI
pRH258 pcDNA3.1-HA-m!-cat-E664A (aa 410-781)
pRH224 BamHI x NotI ligated into pRH231 BamHI x NotI
pRH259 pcDNA3.1-HA-LgsN2-eGFP (aa 1-782)
pRE356 XhoI x XbaI ligated into pOP221 XhoI x XbaI
pRH260 pcDNA3.1-NLS-HA-LgsN2-eGFP (aa 1-782)
pRE356 XhoI x XbaI ligated into pOP244 XhoI x XbaI
pRH261 pcDNA3.1-HA-LgsN2-!HD1-eGFP (aa 1-782)
pRH245 ScaI ligated into pRH259 ScaI
pRH262 pcDNA3.1-NLS-HA-LgsN2-!HD1-eGFP (aa 1-782)
pRH240 ScaI ligated into pRH259 ScaI
pRH263 pPacPL-HA-LgsN2-eGFP (aa 1-782)
pRH259 Asp718 x XbaI blunt ligated into pRE262 Asp718 x NotI blunt
pRH264 pPacPL-NLS-HA-LgsN2-eGFP (aa 1-782)
pRH260 Asp718 x XbaI blunt ligated into pRE262 Asp718 x NotI blunt
pRH265 pPacPL-HA-LgsN2-!HD1-eGFP (aa 1-782)
pRH261 Asp718 x XbaI blunt ligated into pRE262 Asp718 x NotI blunt
pRH266 pPacPL-NLS-HA-LgsN2-!HD1-eGFP (aa 1-782)
pRH262 Asp718 x XbaI blunt ligated into pRE262 Asp718 x NotI blunt
pRH267 pUAST-CD2-m!-cat-S33Y-Y142A
pRH249 Asp718 x NotI blunt ligated into pUAST Asp718 x XbaI blunt
pRH268 pcDNA3.1-hPygo2!74-78
pRH250 XbaI blunt x NotI ligated into pcDNA3.1 EcoRV x NotI
pRH269 pcDNA3.1-hPygo2!Thomas
pRH251 XbaI blunt x NotI ligated into pcDNA3.1 EcoRV x NotI
pRH270 pPacPL-FLAG-mBCL9.2-FL
p85 NheI x XbaI ligated into pRE402 XbaI x NheI
pRH271 pPacPL-FLAG-mBCL9.2-!138-173
p86 NheI x XbaI ligated into pRE402 XbaI x NheI
pRH272 pPacPL-FLAG-mBCL9.2-!PyBD
p87 NheI x XbaI ligated into pRE402 XbaI x NheI
pRH273 pBTM116-HA-LgsN (aa 1-782)
pRH263 EcoRV x XhoI ligated into pBTM116.2 SmaI x XhoI
pRH274 pGAD424-mß-cat!C (aa 1-673)
pRH172 BamHI x NotI ligated into pRH143 BamHI x NotI
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pRH275 pcDNA3.1-G4DBD-m!-cat-S33Y-!C-V5/His
pRH194 SpeI ligates into pRH189 SpeI
pRH276 pcDNA3.1-G4DBD-m!-cat-S33Y-D164A-!C-V5/His
pRH199 SpeI ligates into pRH189 SpeI
pRH277 pBS-m!-cat-R1-4-wt  (aa 141-306)
PCR on p30 with mß-catR1 f and mß-catR4 r ligated into pBS BamHI x NotI
pRH278 pBS-m!-cat-R1-4-D164A  (aa 141-306)
PCR on pRH199 with mß-catR1 f and mß-catR4 r ligated into pBS BamHI x NotI
pRH279 pBS-m!-cat-R1-4-Y142A  (aa 141-306)
PCR on pRH205 with mß-catR1-Y142A f and mß-catR4 r ligated into pBS BamHI x NotI
pRH280 pcDNA3.1-NLS-G4DBD-BCL9-HA (tub trailer)
pTK006 SalI blunt x NotI ligated into pRH312 EcoRV x NotI
pRH281 pcDNA3.1-NLS-G4DBD-BCL9!HD1-HA (tub trailer)
pTK136 SalI blunt x NotI ligated into pRH312 EcoRV x NotI
pRH282 pcDNA3.1-NLS-G4DBD-FLAG-mBCL9.2-FL
p85 NheI x EcoRI ligated into pRH312 NheI x EcoRI
pRH283 pcDNA3.1-NLS-G4DBD-FLAG-mBCL9.2-!138-173
p86 NheI x EcoRI ligated into pRH312 NheI x EcoRI
pRH284 pcDNA3.1-NLS-G4DBD-FLAG-mBCL9.2-!PyBD
p87 NheI x EcoRI ligated into pRH312 NheI x EcoRI
pRH285 pBS-Arm(myc)-D172A (contains tub-trailer)
pDA725 Asp718 x XbaI ligated into pBS Asp718 x XbaI
pRH286 pBS-Arm
S10
-D172A (myc) (contains tub-trailer)
pDA722 Asp718 x XbaI ligated into pBS Asp718 x XbaI
pRH287 pBS-Arm-!C-HA (aa 1-690)
pRE008 ApaI x XbaI ligated into pRH186 ApaI x XbaI
pRH288 pBS-Arm
S10
-!C-HA (aa 1-690)
pRE008 ApaI x XbaI ligated into pRH187 ApaI x XbaI
pRH289 pBS-Arm-D172A-!C-HA (aa 1-690)
pRE008 ApaI x XbaI ligated into pRH285 ApaI x XbaI
pRH290 pBS-Arm
S10
-D172A-!C-HA (aa 1-690)
pRE008 ApaI x XbaI ligated into pRH286 ApaI x XbaI
pRH291 pGAD424-m!-cat-R1-4-wt (aa 141-306)
pRH277 BamHI x NotI ligated into pRH143 BamHI x NotI
pRH292 pGAD424-m!-cat-R1-4-D164A (aa 141-306)
pRH278 BamHI x NotI ligated into pRH143 BamHI x NotI
pRH293 pGAD424-m!-cat-R1-4-Y142A (aa 141-306)
pRH279 BamHI x NotI ligated into pRH143 BamHI x NotI
pRH294 ptub-Arm-!C-HA (aa 1-690)
pRH287 Asp718 x XbaI ligated into pOP118 Asp718 x XbaI
3. Appendix 79
pRH295 ptub-Arm-D172A-!C-HA (aa 1-690)
pRH289 Asp718 x XbaI ligated into pOP118 Asp718 x XbaI
pRH296 pUAST-Arm
S10
-!C-HA (aa 1-690)
pRH288 Asp718 x XbaI ligated into pUAST Asp718 x XbaI
pRH297 pUAST-Arm
S10
-D172A-!C-HA (aa 1-690)
pRH290 Asp718 x XbaI ligated into pUAST Asp718 x XbaI
pRH298 pGAD424.1-m/h!-cat-Y142F
Quicksite mutagenesis PCR on pRH95 with mbcat Y142Ff/r, can be cut out with BamHI x SalI
pRH299 pPacPL-MCS.2
Oligo MCS.2 ligated into pRE398 BamHI (destroyed) x NotI
pRH300 pBS-Arm
S10
-!C-myc (aa 1-690)
oligo SpeI myc EcoRI ligated into pRH288 SpeI x EcoRI
pRH301 pBS-Arm
S10
-D172A-!C-myc (aa 1-690)
oligo SpeI myc EcoRI ligated into pRH290 SpeI x EcoRI
pRH302 pcDNA3.1-HA-mPygo2-PHD (aa 276-406)
pRH34 BamHI x XhoI ligated into pRH231 BamHI x XhoI
pRH303 pBS-Arm-!C-myc
pRH287 Asp718 x StuI ligated into pRH300 Asp718 x StuI
pRH304 pBS-Arm-D172A-!C-myc
pRH289 Asp718 x StuI ligated into pRH300 Asp718 x StuI
pRH305 pcDNA3.1-NLS-GAL4BD.2-m!-cat-S33Y-wt (aa 1-781)
pRE492 Asp718 x BglII ligated into pRH194 Asp718 x BamHI
pRH306 pcDNA3.1-NLS-GAL4BD.2-m!-cat-S33Y-D164A (aa 1-781)
pRE492 Asp718 x BglII ligated into pRH199 Asp718 x BamHI
pRH307 pcDNA3.1-NLS-GAL4BD
pRE492 Asp718 x HpaI ligated into pRH171 Asp718 x HpaI
pRH308 pcDNA3.1-NLS-GAL4BD-HA (stop after HA)
pRE492 Asp718 x HpaI ligated into pRE428 Asp718 x HpaI
pRH309 pPacPL-BCL9-HA
pTK006 HindIII blunt x SalI ligated into pRH299 EcoRV x XhoI
pRH310 ptub-Arm!C-myc
pRH303 Asp718 x XbaI ligated into pOP118 Asp718 x XbaI
pRH311 ptub-Arm!C-D172A-myc
pRH304 Asp718 x XbaI ligated into pOP118 Asp718 x XbaI
pRH312 pcDNA3.1-NLS-G4DBD-MCS new
oligo BamHI MCS XbaI ligated into pRH307 Asp718 x XbaI
pRH313 pPacPL-BCL9!HD1-HA
pTK136 Asp718 ligated into pRH309 Asp718
pRH314 pcDNA3.1-BCL9-HA
pTK006 SalI blunt x NotI ligated into pcDNA3.1 EcoRV x NotI
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pRH315 pcDNA3.1-BCL9!HD1-HA
pTK106 SalI blunt x NotI ligated into pcDNA3.1 EcoRV x NotI
pRH316 pBS-Arm
S10
-!C-NLS-HA
pRE008 ApaI x SpeI ligated into pRE034 ApaI x SpeI
pRH317 pPacPL-Arm-D172A-NLS-HA
pRH289 Asp718 x ApaI ligated into pRE367 Asp718 x ApaI
pRH318 pBS-Arm-!C-wt-NLS-HA (contains tub trailer)
pRH186 Asp718 x ApaI ligated into pRH316 Asp718 x ApaI
pRH319 pBS-Arm-!C-D172A-NLS-HA (contains tub trailer)
pRH285 Asp718 x ApaI ligated into pRH316 Asp718 x ApaI
pRH320 pPacPL-Arm-wt-!C-NLS-HA (aa 1-690)
pRH318 Asp718 x XbaI ligated into pRH299 Asp718 x XbaI
pRH321 pPacPL-Arm-D172A-!C-NLS-HA (aa 1-690)
pRH319 Asp718 x XbaI ligated into pRH299 Asp718 x XbaI
pRH322 pBS-m!-cat-cat w/o STOP (aa 1-781)
PCR on p30 with mß-cat-Asp718 and mß-cat XhoI r ligated into pBS Asp718 x XhoI
pRH323 pUAST-Arm
S10
-!C-myc
pRH300 Asp718 x XbaI ligated into pUAST Asp718 x XbaI
pRH324 pUAST-Arm
S10
-D172A-!C-myc
pRH301 Asp718 x XbaI ligated into pUAST Asp718 x XbaI
pRH325 pBS-hP300
p77 HindIII x NotI ligated into pBS HindIII x NotI
pRH326 pBS-hP300-HA
p78 HindIII x NotI ligated into pBS HindIII x NotI
pRH327 pBS-hPygo2-!NHD
pRE329 BglII x NotI ligated into pRE344 BglII x NotI
pRH328 pcDNA3.1-hPygo2-!NHD
pRH327 XbaI blunt x NotI ligated into pRE319 Asp718 x NotI
pRH329 pPacPL-V5
Oligo Asp718 V5 NheI ligated into pRH299 Asp718 x NheI
pRH330 pPacPL-FLAG
Oligo Asp718 FLAG NheI ligated into pRH299 Asp718 x NheI
pRH331 pBS-hP300 (aa 1-580)
pRH325 EcoRV x BstBI blunt religated
pRH332 pBS-hP300 (aa 1-1257)
pRH325 EcoRV x BglII blunt religated
pRH333 pBS-hP300 (aa 1-1944)
pRH325 EcoRV x PmlI religated
pRH334 pCR2.1-eGFP (without Kozak and ATG)
PCR on pRE365 with XhoI GFP f and eGFP STOP EcoRI, TOPO cloned
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pRH335 pBS-HR1
PCR m. gen. DNA with Spe Pac HR1 f and Not (mut) HR1 r1, ligated into pBS SpeI x NotI
pRH336 pBS-HR2a
PCR m. gen. DNA with Eco Asc HR2a f1 and Xho HR2a r, ligated into pBS EcoRI x XhoI
pRH337 pBS-HR2b
PCR m. gen. DNA with Xho HR2b f and Apa HR2b r, ligated into pBS XhoI x ApaI
pRH338 pBS-HR2c
PCR m. gen. DNA with Apa HR2c f and Asp718 Pme HR2c r, ligated into pBS ApaI x Asp718
PRH339 pcDNA3.1-m!-cat-eGFP
pRH322 Asp718 x XhoI & pRH334 XhoI x NotI ligated into pcDNA3.1 Asp718 x NotI
pRH340 pTargetVector-HR1
pRH335 PacI x NotI ligated into pT.V. PacI x NotI
pRH341 pBS-HR2
pRH337 XhoI x ApaI & pRH338 ApaI x Asp718 ligated into pRH336 XhoI x Asp718
pRH342 pMZ55-FLAG-BCL9.2-FL-tub trailer (intermediate)
p85 HindIII x EcoRI ligated into pMZ55 HindIII x EcoRI
pRH343 pMZ55- FLAG-BCL9.2-!PyBD-tub trailer (intermediate)
p87 HindIII x EcoRI ligated into pMZ55 HindIII x EcoRI
pRH344 pcDNA3.1-NLS-G4DBD-m!-cat-S33Y-!C-V5/His
pRH305 Asp718 x BbrPI ligated into pRH275 Asp718 x BbrPI
pRH345 pcDNA3.1-NLS-G4DBD-m!-cat-S33Y-D164A-!C-V5/His
pRH305 Asp718 x BbrPI ligated into pRH276 Asp718 x BbrPI
pRH346 pPacPL-FLAG-m!-cat-S33Y-wt
pRH194 BamHI x XbaI ligated into pRH330 BamHI x XbaI
pRH347 pPacPL-FLAG-m!-cat-S33Y-D164A
pRH199 BamHI x XbaI ligated into pRH330 BamHI x XbaI
pRH348 pPacPL-FLAG-m!-cat-S33Y-Y142A
pRH205 BamHI x XbaI ligated into pRH330 BamHI x XbaI
pRH349 pPacPL-FLAG-m!-cat-S33Y-Y142E
pRH208 BamHI x XbaI ligated into pRH330 BamHI x XbaI
pRH350 pPacPL-FLAG-m!-cat-S33Y-Y142D
pRH213 BamHI x XbaI ligated into pRH330 BamHI x XbaI
pRH351 pcDNA3.1-m!-cat-S33Y-eGFP
pRH114 Asp718 x BbrPI ligated into pRH339 Asp718 x BbrPI
pRH352 pTargetVector-HR1-HR2
pRH341 PmeI x AscI blunt ligated into pRH340 PmeI
pRH353 pBS-HR3
PCR m. gen. DNA with EcoRI PacI HR3 f.1 and Not HR3 r.1, ligated into pBS EcoRI x NotI
pRH354 pBS-HR4a
PCR m. gen. DNA with Sal Asc HR4a f and EcoRI HR4a r, ligated into pBS SalI x EcoRI
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pRH355 pBS-HR4b
PCR m. gen. DNA with EcoRI HR4b f and XmaI HR4b r, ligated into pBS EcoRI x XmaI
pRH356 pBS-HR4c
PCR m. gen. DNA with XmaI HR4c f.1 and XbaI HR4c r.1, ligated into pBS XmaI x XbaI
pRH357 pBS-HR4d
PCR m. gen. DNA with XbaI HR4d f and Not Pme HR4d r, ligated into pBS XbaI x NotI
pRH358 ptub-FLAG-BCL9.2-FL
pRH342 HindIII blunt x XbaI ligated into pOP118 Asp718 x XbaI
pRH359 ptub-FLAG-BCL9.2-!PyBD
pRH343 HindIII blunt x XbaI ligated into pOP118 Asp718 x XbaI
pRH360 pTargetVector-HR3
pRH353 PacI x NotI ligated into pT.V. PacI x NotI
pRH361 pBS-HR4a-4b
pRH355 EcoRI x XbaI ligated into pRH354 EcoRI x XbaI
pRH362 pBS-HR4c-4d
pRH357 XbaI x NotI ligated into pRH356 XbaI x NotI
pRH363 pPacPL-V5-dCBP stop in between V5 and dCBP
p80 BstBI x NotI ligated into pRH329 BstBI x NotI
pRH364 pPacPL-FLAG-dCBP stop in between FLAG and dCBP
p80 BstBI x NotI ligated into pRH330 BstBI x NotI
pRH365 pBS-HR4
pRH361 XmaI x NotI ligated into pRH362 XmaI x NotI
pRH366 pPGS-CMV-CITE-NEO-m!-cat-S33Y-eGFP
pRH351 Asp718 x XbaI blunt ligated into pPGS-CMV- EcoRI blunt
pRH367 pBS-HR1+
PCR m. gen. DNA with Spe Pac HR1f test and Not (mut) HR1 r1, ligated into pBS SpeI x NotI
pRH368 pBS-HR3+
PCR m. gen. DNA with EcoRI PacI HR3f test and Not HR3 r.1, ligated into pBS EcoRI x NotI
pRH369 pcDNA3.1-HA-hP300-CH1 (aa 301-388)
PCR with Bam hP300 900f and Xba hP300 r, ligated into pRH231 BamHI x XbaI
pRH370 pcDNA3.1-HA-hP300 (aa 1-388)
PCR with Bam hP300 f and Xba hP300 r, ligated into pRH231 BamHI x XbaI
pRH371 pGEX-4T2-hBCL9.2 (HD1 + 2)
pRH148 BamHI x NotI ligated into pGEX-4T2 BamHI x NotI
pRH372 pcDNA3.1-m!-cat-S33Y-wt
pRH346 Asp718 x XbaI ligated into pcDNA3.1 Asp718 x XbaI
pRH373 pcDNA3.1-m!-cat-S33Y-D164A
pRH347 Asp718 x XbaI ligated into pcDNA3.1 Asp718 x XbaI
pRH374 pcDNA3.1-m!-cat-S33Y-Y142A
pRH348 Asp718 x XbaI ligated into pcDNA3.1 Asp718 x XbaI
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pRH375 pcDNA3.1-m!-cat-S33Y-Y142E
pRH349 Asp718 x XbaI ligated into pcDNA3.1 Asp718 x XbaI
pRH376 pcDNA3.1-m!-cat-S33Y-Y142D
pRH350 Asp718 x XbaI ligated into pcDNA3.1 Asp718 x XbaI
pRH377 pTargetVector-HR1+
pRH367 PacI x NotI ligated into pT.V. PacI x NotI
pRH378 pTargetVector-HR3+
pRH368 PacI x NotI ligated into pT.V. PacI x NotI
pRH379 pCDNA3.1-HA-mBCL9.2 (aa 2-556) intermediate, HA not in frame
PCR with mBCL9.2 f and mBCL9.2 556 r, ligated into pRH231 BamHI x XbaI
pRH380 pCDNA3.1-FLAG-mBCL9.2 (aa 1-556)
pRH379 BamHI x XbaI ligated into p85 BamHI x XbaI
pRH381 pBS-attB-UAS-Arm
S10
(myc)-wt
pDA720 Asp718 x XbaI ligated into pBS-attB-UAS Asp718 x XbaI
pRH382 pBS-attB-UAS-Arm
S10
(myc)-Y150A
pRH192 Asp718 x XbaI ligated into pBS-attB-UAS Asp718 x XbaI
pRH383 pBS-attB-UAS-Arm
S10
(myc)-D172A
pDA722 Asp718 x XbaI ligated into pBS-attB-UAS Asp718 x XbaI
pRH384 pGAD424-Arm(myc)-Y150A (aa 38-806)
pRH191 PinAI x StuI ligated into pRH102 PinAI x StuI
pRH385 pBTM116-d"-catenin (aa 1-394)
pRH126 EcoRI x SalI ligated into pBTM116 EcoRI x SalI
pRH386 pBS-attB-tub-prom
pOP118 EcoRI x StuI blunt ligated into pBS-attB-UAS BamHI blunt
pRH387 pBS-attB-tub-Arm(myc)-wt
pDA716 Asp718 x XbaI ligated into pRH386 Asp718 x XbaI
pRH388 pBS-attB-tub-Arm(myc)-Y150A
pRH191 Asp718 x XbaI ligated into pRH386 Asp718 x XbaI
pRH389 pBS-attB-tub-Arm(myc)-D172A
pDA725 Asp718 x XbaI ligated into pRH386 Asp718 x XbaI
pRH390 pPacPL-FLAG-m/h!-cat-wt
pRH95 BamHI x SalI ligated into pRH330 BamHI x XhoI
pRH391 pPacPL-FLAG-m/h!-cat-Y142A
pRH137 BamHI x SalI ligated into pRH330 BamHI x XhoI
pRH392 pPacPL-FLAG-m/h!-cat-D164A
pRH99 BamHI x SalI ligated into pRH330 BamHI x XhoI
pRH393 pPacPL-hP300-HA
pRH326 HindIII blunt x NotI ligated into pRH299 HpaI x NotI
pRH394 pTV-HR3-HR4 (LoxP-FRT-neo-FRT)
pRH361 AscI x XmaI and pRH362 PmeI x XmaI ligated into pRH360 AscI x PmeI
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pRH395 pBS-attB-tub-FLAG-mBCL9.2-wt
pRH358 PacI x XbaI ligated into pRH386 PacI x XbaI
pRH396 pBS-attB-tub-FLAG-mBCL9.2-!PyBD
pRH359 PacI x XbaI ligated into pRH386 PacI x XbaI
pRH397 pBS-attB-tub-prom-3'UTR
pMZ55 EcoRI x XbaI blunt ligated into pRH386 XhoI blunt
pRH398 pTV.1-HR3-HR4 (FRT-neo-FRT)
pRH353 EcoRI x NotI blunt ligated into pRH394 SacII blunt
pRH399 pcDNA3.1-NLS-G4DBD
oligo BglII HA BamHI ligated into pRH307 BglII x BamHI
pRH401 pPacPL-FLAG-mBCL9.2!C (aa 1-556)
pRH380 NheI x XbaI ligated into pRH299 NheI
pRH402 pcDNA3.1-NLS-G4DBD-HA-m!-cat-wt
pRH399 Asp718 x BamHI ligated into pRH194 Asp718 x BamHI
pRH403 pcDNA3.1-NLS-G4DBD-HA-m!-cat-D164A
pRH399 Asp718 x BamHI ligated into pRH199 Asp718 x BamHI
pRH404 pcDNA3.1-NLS-G4DBD-HA-m!-cat-!C
pRH399 Asp718 x BamHI ligated into pRH275 Asp718 x BamHI
pRH405 pcDNA3.1-NLS-G4DBD-HA-m!-cat-D164A-!C
pRH399 Asp718 x BamHI ligated into pRH276 Asp718 x BamHI
pRH406 pcDNA3.1-NLS-G4DBD-HA-m!-cat-Y142A
pRH399 Asp718 x BamHI ligated into pRH205 Asp718 x BamHI
pRH409 pBS-loxP-Hyg-loxP-HR2
loxP-Hyg-loxP rev (L-PGK-Hyg#12) ClaI blunt x NotI ligated into pRH341 SmaI x NotI
pRH410 pBS-HR1-loxP-Hyg-loxP-HR2-TK
pRH409 NotI x PmeI ligated into pRH340 NotI x PmeI
pRH411 pBS-HR1+-loxP-Hyg-loxP-HR2-TK
pRH409 NotI x PmeI ligated into pRH377 NotI x PmeI
pRH412 pcDNA3.1-NLS-VP16act-mCBP
p76 BamHI ligated into pRE629 BamHI
pRH413 pcDNA3.1-HA-mBCL9.2-FL
oligo NheI HA BamHI ligated into p85 NheI x BamHI
pRH414 pCS2-mb-cat!C-wt
PCR with SpeI mb-cat 536f x RI mb-cat!C r ligated into p95 SpeI x ClaI
pRH415 pCS2-mb-cat!C-D164A
PCR with SpeI mb-cat 536f x RI mb-cat!C r ligated into p96 SpeI x ClaI
pRH416 pAAV-mb-cat!C-wt
pRH414 StuI ligated into p97 StuI
pRH417 pAAV-mb-cat!C-D164A
pRH414 StuI ligated into p98 StuI
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pRH418 pUAST-Arm-D164A
p47 Asp718 x XbaI ligated into pUAST Asp718 x XbaI
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3.2 Constructs gifts
p1 pGAD424-h!-cat 3-C'WT' (aa 196-781) cut out BamHI/SalI (von Kries, Berlin)
p2 pGAD424-h!-cat WT-R (aa 196-781) cut out BamHI/SalI (von Kries, Berlin)
p3 pGAD424-h!-cat R225A (aa 216-781) cut out BamHI/SalI (von Kries, Berlin)
p4 pGAD424-h!-cat F253A (aa 216-781) cut out BamHI/SalI (von Kries, Berlin)
p5 pGAD424-h!-cat H260A (aa 216-781) cut out BamHI/SalI (von Kries, Berlin)
p6 pGAD424-h!-cat K270A (aa 216-781) cut out BamHI/SalI (von Kries, Berlin)
p7 pGAD424-h!-cat R274A (aa 216-781) cut out BamHI/SalI (von Kries, Berlin)
p8 pGAD424-h!-cat K292A (aa 216-781) cut out BamHI/SalI (von Kries, Berlin)
p9 pGAD424-h!-cat W338A (aa 216-781) cut out BamHI/SalI (von Kries, Berlin)
p10 pGAD424-h!-cat R342A (aa 216-781) cut out BamHI/SalI (von Kries, Berlin)
p11 pGAD424-h!-cat K345A (aa 216-781) cut out BamHI/SalI (von Kries, Berlin)
p12 pGAD424-h!-cat K354A (aa 216-781) cut out BamHI/SalI (von Kries, Berlin)
p13 pGAD424-h!-cat R376A (aa 216-781) cut out BamHI/SalI (von Kries, Berlin)
p14 pGAD424-h!-cat W383A (aa 216-781) cut out BamHI/SalI (von Kries, Berlin)
p15 pGAD424-h!-cat R386A (aa 216-781) cut out BamHI/SalI (von Kries, Berlin)
p16 pGAD424-h!-cat K394A (aa 216-781) cut out BamHI/SalI (von Kries, Berlin)
p17 pGAD424-h!-cat K435A (aa 216-781) cut out BamHI/SalI (von Kries, Berlin)
p18 pGAD424-h!-cat R457A (aa 216-781) cut out BamHI/SalI (von Kries, Berlin)
p19 pGAD424-h!-cat R469A (aa 216-781) cut out BamHI/SalI (von Kries, Berlin)
p20 pGAD424-h!-cat H470A (aa 216-781) cut out BamHI/SalI (von Kries, Berlin)
p21 pGAD424-h!-cat W504A (aa 216-781) cut out BamHI/SalI (von Kries, Berlin)
p22 pGAD424-h!-cat N516A (aa 216-781) cut out BamHI/SalI (von Kries, Berlin)
p23 pGAD424-h!-cat L427E (aa 216-781) cut out BamHI/SalI (von Kries, Berlin)
p24 pGAD424-h!-cat E462A (aa 216-781) cut out BamHI/SalI (von Kries, Berlin)
p25 pGAD424-h!-cat N426A (aa 216-781) cut out BamHI/SalI (von Kries, Berlin)
p26 pGAD424-h!-cat N430A (aa 216-781) cut out BamHI/SalI (von Kries, Berlin)
p27 pBTM116-mAPC  (aa 1152-1393) (von Kries, Berlin)
p28 pBTM116-mE-cadherin (last 111 aa C-terminus) (von Kries, Berlin)
p29 pBS-m"-cat (Kemler, Freiburg)
p30 pCDNA3-m!-cat (w/o KOZAK Barbara, TGC)
p31 pCDNA-!N-!-cat (aa 132-781) (Max, TGC)
p32 pBS-Arm
S10 
(George)
p33 pKB342 pBS + tubulin 3' UTR (George)
p34 pTK264 pUAS-!Narm-wt (Thomas)
p35 pTK265 pUAS-!Narm-E171A (Thomas)
p36 pTK266 pUAS-!Narm-D172A (Thomas)
p37 pTK267 pBS-!Narm-A303W/I304W (Thomas)
p38 pTK269 pUAS-!Narm-K443E (Thomas)
p39 pDA703 pBS-arm-wt (Denise)
p40 pDA704 pBS-arm-E171A (Denise)
p41 pDA705 pBS-arm-D172A (Denise)
p42 pDA734 pBS-arm-A303W/I304W (Denise)
p43 pDA707 pBS-arm-K443E (Denise)
p44 pDA715 tub-(myc)arm-E171A (Denise)
p45 pDA716 tub-(myc)arm-wt (Denise)
p46 pDA719 tub-(myc)arm-K443E (Denise)
p47 pDA725 tub-(myc)arm-D172A (Denise)
p48 pDA736 tub-(myc)arm-A303W/I304W (Denise)
p49 pTK293 tub-myr-(HA)-arm-wt (Thomas)
p50 pTK294 tub-myr-(HA)-arm-E171A (Thomas)
p51 pTK299 tub-myr-(HA)-arm-D172A (Thomas)
p52 pTK347 tub-myr-(HA)-arm-A303W/I304W (Thomas)
p53 pTK348 tub-myr-(HA)-arm-K443E (Thomas)
p54 pCMV-Lef (Liang)
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p55 pCDNA-BCL9 (Barbara, TGC)
p56 pCDNA-hPygo1 (Barbara, TGC)
p57 pCDNA-hPygo2 (Barbara, TGC)
p59 pPGS-CMV-S33Y-h!-cat (Eliane Müller, Bern)
p60 pCDNA-!N-ß-cat (aa 132-781) (Max, TGC) new
p61 pBS-hDvl2 (Sussman, Baltimore)
p62 pSVK3-hDvl2 (Sussman, Baltimore)
p63 pGAD-Ketel
p64 pBS-Ketel
p65 XBC-HA (Kimelman, Seattle)
p66 pBS-hPG (Eliane Müller, Bern)
p68 pPGS-!NTCF (Fearon, Ann Arbor)
p69 OT2-d"-cat (EST)
p70 M50 Super8xTOPflash (Moon, Seattle)
p71 M51 Super8xFOPflash (Moon, Seattle)
p72 pAc-LacZ
p73 pMT/V5/HisB-Gal4DB-Pygo (Reto pRE145)
p74 pMT/V5/HisB-Pygo (Reto pRE147)
p75 pGEM3Zf-mWnt3a (Nusse, Stanford)
p76 pCDNA3-mCBP-HA (Eckner, Newark)
p77 CMVß-hP300-wt (Eckner, Newark)
p78 CMVß-hP300-HA (Eckner, Newark)
p79 pBS-hLgs2 (HD1+HD2) (Pierre, TGC)
p80 pBS-dCBP (Smolik, Portland)
p81 pBS-Arm (George)
p82 pCDNA3-Arm (George)
p83 pGEX-4T-1-GST-hP300-CH3 (aa 1710-1891) (Weis, Stanford)
p84 pGEX-4T-3-GST-hICAT (Weis, Stanford)
p85 pCDNA3.1-FLAG-mBCL9.2-FL (Birchmeier, Berlin)
p86 pCDNA3.1-FLAG-mBCL9.2-!138-173 (Birchmeier, Berlin)
p87 pCDNA3.1-FLAG-mBCL9.2-!PyBD (Birchmeier, Berlin)
p88 pDA720 pUAST-ArmS10(myc)-wt (Denise)
p89 pDA721 pUAST-ArmS10(myc)-E171A (Denise)
p90 pDA722 pUAST-ArmS10(myc)-D172A (Denise)
p91 pDA737 pUAST-ArmS10(myc)-A303W/I304W (Denise)
p92 pDA724 pUAST-ArmS10(myc)-K443E (Denise)
p93 L-PGK-Hyg#12 (loxP-Hyg-loxP rev) (Shmerling, Polygene)
p94 pTargetVector pBS-FRT-neo-FRT-TK (Aguet, Lausanne)
p95 pCS2-m!-cat(6 x myc)-wt (Kemler, Freiburg)
p96 pCS2-m!-cat(6 x myc)-D164A (Kemler, Freiburg)
p97 pAAV-m!-cat(6 x myc)-wt (Kemler, Freiburg)
p98 pAAV-m!-cat(6 x myc)-D164A (Kemler, Freiburg)
p99 pDU10 (ESBATech, Zurich)
p100 pDU12 (ESBATech, Zurich)
p101 pDU13 (ESBATech, Zurich)
p102 pDU46 (ESBATech, Zurich)
p103 pDU62 (ESBATech, Zurich)
p104 pDU63 (ESBATech, Zurich)
p105 pDU106 (ESBATech, Zurich)
p106 pDU153 (ESBATech, Zurich)
p107 pDU198 (ESBATech, Zurich)
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3.3 Oligonucleotides
Apa HR2b r caccagggccctgcctag
Apa HR2c f ctaggcagggccctggtg
Arm Y150Af1 ggtcaatctgatcaacgcccaggacgacgctgagc
Arm Y150Ar1 gctcagcgtcgtcctgggcgttgatcagattgacc
Asp718 Pme HR2c r gctaggtaccgtttaaacccataatgaaggcgaacggc
Bam f mbcat atggatccaccaccatggctactcaagctgacctg
Bam hP300 900f gtacggatccaacatgggtcaacagccagc
Bam hP300 f tagcggatccatggccgagaatgtggtgg
Bam mbcat atggatccatgttgaaacatgcagttgtc
BCL9 199 Xba f attctagaatgactatcgtctctttccacatc
BCL9 392 Not r tagcggccgccaggattctgctgcggtcc
BCL9 732 S. NheI atgctagcggccgctcacatctgagagttggatcccatg
BglII K. BCL9 atagatctaccaccatgcattccagtaaccctaaag
D162A f mbcatD164A gctgacaaaactgctaaacgctgaggcccaggtggtag
D162A r mbcatD164A ctaccacctgggcctcagcgtttagcagttttgtcagc
da-cat EcoRI atgaattcatgttaaaacctgataaaatggg
da-cat SalI atgtcgacgaaacatgatccacaacagcc
dE-cad (EcoRI) gcgaattcgcagtggtggtgcagaaaaagc
Eco Asc HR2a f1 tagcgaattcggcgcgcccagtgatgtaacttgcttttcag
EcoRI HR4a r ctgagaattcttaccgcttcttgtaatcctgtgg
EcoRI HR4b f tcaggaattcccagctaccgttcttttcac
EcoRI PacI HR3 f.1 tacggaattcttaattaagttgtgggttagatcttgcatgc
EcoRI PacI HR3f test tacggaattcttaattaaggtgaactgttagcagggagc
Gal4BD Asp718 f atggtaccaccatgaagctactgtcttctatcg
Gal4BD Bam r taggatcccgatacagtcaactgtctttg
hbcat D164Af ctgctaaatgacgaggcccaggtggtggttaataag
hbcat D164Ar cttattaaccaccacctgggcctcgtcatttagcag
hbcat E163Af caaaactgctaaatgacgcggaccaggtggtgg
hbcat E163Ar ccaccacctggtccgcgtcatttagcagttttg
hbcat R386Af ctgtctttggactctcgcgaatctttcagatgctg
hbcat R386Ar cagcatctgaaagattcgcgagagtccaaagacag
hbcat-XbaI agtctagattacaggtcagtatcaaaccagg
hLgs2 HD1+2f atgaattctcgcagttcgtatatgtcttc
hLgs2 HD1+2r atgcggccgcttgaggaagggctcagtctc
hP300 CH3f atggatccttctcttcactccgaagagc
hP300 CH3r atgcggccgcatctggtgttggattggc
hTCF4 Not r tagcggccgctctggagataggttcgggc
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hTCF4 Xba f attctagaatgccgcagctgaacggcgg
m.m.Lef EcoRI tcgaattccaccatgccccaactttccggagg
m.m.Lef XbaI agtctagaatgtaggcagctgtcattctgg
mbcat D164A f ctgctaaacgatgaggcccaggtggtagttaataaagc
mbcat D164A r gctttattaactaccacctgggcctcatcgtttagcag
mbcat E664Af ctattccgaatgtctgcggacaagccacaggattac
mbcat E664Ar gtaatcctgtggcttgtccgcagacattcggaatag
mbcat F660A on E664Af gcagctgctgtcctagcccgaatgtctgcggac
mbcat F660A on E664Ar gtccgcagacattcgggctaggacagcagctgc
mbcat F660Af gcagctgctgtcctagcccgaatgtctgaggac
mbcat F660Ar gtcctcagacattcgggctaggacagcagctgc
mbcat R661A on F660Af gctgctgtcctagccgcaatgtctgaggacaag
mbcat R661A on F660Ar cttgtcctcagacattgcggctaggacagcagc
mbcat R661Af gctgctgtcctattcgcaatgtctgaggacaag
mbcat R661Ar cttgtcctcagacattgcgaataggacagcagc
mbcat XhoIr tcagctcgagtacaggtcagtatcaaaccagg
mbcat Y142Af gttgtcaatttgattaacgctcaggatgacgcggaac
mbcat Y142Ar gttccgcgtcatcctgagcgttaatcaaattgacaac
mbcat Y142Df gttgtcaatttgattaacgatcaggatgacgcggaac
mbcat Y142Dr gttccgcgtcatcctgatcgttaatcaaattgacaac
mbcat Y142Ef gttgtcaatttgattaacgaacaggatgacgcggaac
mbcat Y142Er gttccgcgtcatcctgttcgttaatcaaattgacaac
mbcat Y142Ff gttgtcaatttgattaactttcaggatgacgcggaac
mbcat Y142Fr gttccgcgtcatcctgaaagttaatcaaattgacaac
mbcat Y654Af gaaggcgtggcaacagccgcagctgctgtcctattc
mbcat Y654Ar gaataggacagcagctgcggctgttgccacgccttc
mbcat Y654Ef gaaggcgtggcaacagaagcagctgctgtcctattc
mbcat Y654Er gaataggacagcagctgcttctgttgccacgccttc
mbcat!C NotI atgcggccgctccgcttcttgtaatcctgtgg
mbcat-Asp718 caggtaccaccatggctactcaagctgacctg
mb-catR1-f atgaattcggatccaactatcaggatgacgcggaac
mb-catR1-Y142A f atgaattcggatccaacgctcaggatgacgcggaac
mb-catR4-r atgcggccgcataagctaagatctgaaggcag
mBCL9.2 556 r cgtatctagattccgcggcccatcataccccccattcc
mBCL9.2 f ggccgctgaggatcctgg
mCBP 316 NotI r atgcggccgccggtaccagtcattcccatc
mCBP XbaI f attctagaatggccgagaacttgctgg
mWnt3a f agaagcttaccaccatggctcctctcggatacctc
mWnt3a r ctgaattcaatctagactcttgcaggtgtgcacgtcatag
Not (mut) HR1 r1 ctgagcggccgcctgcttacctgggcctcatc
3. Appendix 90
Not HR3 r.1 cgtagcggccgctcctcagcttacccacgcc
Not Pme HR4d r cgtagcggccgcgtttaaacggtcatatggttggcctagg
RI mbcat!C r gcatgaattcatcgatgggatccccgcttcttgtaatcctgtgg
Sal Asc HR4a f tcaggtcgacggcgcgccgagcccagtcccattagttg
SpeI mbcat 536 f gctattccacgactagttcag
Spe Pac HR1 f tcagactagttaattaaggagatgttacactattgaatc
Spe Pac HR1f test tcagactagttaattaagtgtgtcactttgaactgtgg
Xba hP300 r tcagtctagagtagcaagacttgcctgactgg
XbaI HR4c r.1 gatctctctctagagaacag
XbaI HR4d f gtctgttctctagagagagatc
Xho HR2a r caccacctcgagctagagc
Xho HR2b f gctctagctcgaggtggtg
XhoI GFP f ctcgagcgtgagcaagggcgaggagc
XmaI HR4b r cagacagcccgggtacccc
XmaI HR4c f.1 gggtacccgggctgtctgg
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3.4 Fly Stocks
Abbreviations
'X=' = homozygous on X
RH1 arm
2a9
/Bin ; +/+ ; tub-Arm(myc)-D172A Prd-Gal4/TM3 ; +/+
tub-arm-D172A derived from pDA725,2
RH2 arm
2a9
/Bin ; +/+ ; tub-arm-wt Prd-Gal4/TM3 ; +/+
716,4
RH3 y w UAS-RFP/X= ; UAS-Arm
S10
(myc)-D172A UAS-GFP/Cyo ; +/+ ; +/+
722,2
RH4 y w UAS-RFP/X= ; UAS-!Narm-wt UAS-GFP/Cyo ; +/+ ; +/+
RH5 y w UAS-RFP/X= ; UAS-Arm
S10
(myc)-wt UAS-GFP/Cyo ; +/+ ; +/+
RH6 y w UAS-RFP/X= ; Sp/Cyo ; +/+ ; +/+
RH7 w hs-flp hs-GFP FRT18/X= ; +/+ ; tub-Arm-wt/3= ; +/+
716,4
RH8 w hs-flp hs-GFP FRT18/X= ; +/+ ; tub-Arm-D172A/TM6b ; +/+
725,2
RH9 w hs-flp hs-GFP FRT18/X= ; +/+ ; TM6b/MKRS ; +/+
RH10 y w hs-flp/X= ; UAS-!Narm-wt UAS-GFP/2= ; +/+ ; +/+
RH11 y w hs-flp/X= ; UAS-arm
S10
(myc)-wt UAS-GFP/2= ; +/+ ; +/+
RH12 y w hs-flp/X= ; UAS-arm
S10
(myc)-D172A UAS-GFP/Cyo ; +/+ ; +/+
722,2
RH13 w hs-flp hs-GFP FRT18/X= ; +/+ ; tub-myr-Arm-wt/TM6b ; +/+
753,5
RH14a y w hs-flp/X= ; tub-Arm(myc)-wt (716,1)/Cyo ; +/+ ; +/+
Derived from pDA716 (p45)
RH14b y w hs-flp/X= ; tub-Arm(myc)-wt (716,2)/Cyo ; +/+ ; +/+
Derived from pDA716 (p45)
RH14c y w hs-flp/X= ; +/+ ; tub-Arm(myc)-wt (716,4)/TM6b ; +/+
Derived from pDA716 (p45)
RH14d y w hs-flp/X= ; +/+ ; tub-Arm(myc)-wt (716,6)/TM6b ; +/+
Derived from pDA716 (p45)
RH15a y w hs-flp/X= ; +/+ ; tub-Arm(myc)-E171A (715,1)/TM6b ; +/+
Derived from pDA715 (p44)
RH15b y w hs-flp/X= ; +/+ ; tub-Arm(myc)-E171A (715,2)/TM6b ; +/+
Derived from pDA715 (p44)
RH15c y w hs-flp/X= ; tub-Arm(myc)-E171A (715,3)/Cyo ; +/+ ; +/+
Derived from pDA715 (p44)
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RH15d y w hs-flp/X= ; tub-Arm(myc)-E171A (715,6)/Cyo ; +/+ ; +/+
Derived from pDA715 (p44)
RH16a y w hs-flp/X= ; tub-Arm(myc)-D172A (725,1)/Cyo ; +/+ ; +/+
Derived from pDA725 (p47)
RH16b y w hs-flp/X= ; +/+ ; tub-Arm(myc)-D172A (725,2)/TM6b ; +/+
Derived from pDA725 (p47)
RH16c y w hs-flp/X= ; +/+ ; tub-Arm(myc)-D172A (725,3)/3= ; +/+
Derived from pDA725 (p47)
RH16d y w hs-flp/X= ; tub-Arm(myc)-D172A (725,4)/Cyo ; +/+ ; +/+
Derived from pDA725 (p47)
RH17a y w hs-flp/X= ; tub-Arm(myc)-K443E (719,1)/Cyo ; +/+ ; +/+
Derived from pDA719 (p46)
RH17b y w hs-flp/X= ; tub-Arm(myc)-K443E (719,3)/Cyo ; +/+ ; +/+
Derived from pDA719 (p46)
RH17c y w hs-flp/X= ; tub-Arm(myc)-K443E (719,4)/Cyo ; +/+ ; +/+
Derived from pDA719 (p46)
RH18a y w hs-flp/X= ; +/+ ; UAS-!NArm-wt (264,1)/3=; +/+
Derived from pTK264 (p34)
RH18b UAS-!NArm-wt (264,2)/X= ; +/+ ; +/+ ; +/+
Derived from pTK264 (p34)
RH18c y w hs-flp/X= ; +/+ ; UAS-!NArm-wt (264,3)/3= ; +/+
Derived from pTK264 (p34)
RH19a y w hs-flp/X= ; +/+ ; UAS-!NArm-E171A (265,1)/ TM6b ; +/+
Derived from pTK265 (p35)
RH19b y w hs-flp/X= ; +/+ ; UAS-!NArm-E171A (265,3)/TM6b ; +/+
Derived from pTK265 (p35)
RH19c y w hs-flp/X= ; UAS-!NArm-E171A (265,9)/Cyo ; +/+ ; +/+
Derived from pTK265 (p35)
RH20a y w hs-flp/X= ; +/+ ; UAS-!NArm-D172A (266,1)/TM6b ; +/+
Derived from pTK266 (p36)
RH20b y w hs-flp/X= ; +/+ ; UAS-!NArm-D172A (266,3)/3= ; +/+
Derived from pTK266 (p36)
RH20c y w hs-flp/X= ; UAS-!NArm-D172A (266,7)/Cyo ; +/+ ; +/+
Derived from pTK266 (p36)
RH21a y w hs-flp/X= ; UAS-!NArm-K443E (269,1)/2= ; +/+ ; +/+
Derived from pTK269 (p38)
RH21b y w hs-flp/X= ; UAS-!NArm-K443E (269,3)/2= ; +/+ ; +/+
Derived from pTK269 (p38)
RH21c y w hs-flp/X= ; +/+ ; UAS-!NArm-K443E (269,4)/TM6b ; +/+
Derived from pTK269 (p38)
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RH22a y w hs-flp/X= ; UAS-!NArm-A303W/I304W (270,1)/Cyo ; +/+ ; +/+
Derived from pTK270
RH22b y w hs-flp/X= ; UAS-!NArm-A303W/I304W (270,2)/Cyo ; +/+ ; +/+
Derived from pTK270
RH22c y w hs-flp/X= ; +/+ ; UAS-!NArm-A303W/I304W (270,3)/TM6b ; +/+
Derived from pTK270
RH23a y w hs-flp/X= ; UAS-Arm
S10
-wt (720,2)/Cyo ; +/+ ; +/+
Derived from pDA720 (p88)
RH23b y w hs-flp/X= ; +/+ ; UAS-Arm
S10
-wt (720,4)/TM6b ; +/+
Derived from pDA720 (p88)
RH23c y w hs-flp/X= ; +/+ ; UAS-Arm
S10
-wt (720,6)/TM6b ; +/+
Derived from pDA720 (p88)
RH24a y w hs-flp/X= ; +/+ ; UAS-Arm
S10
-E171A (721,1)/TM6b ; +/+
Derived from pDA721 (p89)
RH24b y w hs-flp/X= ; +/+ ; UAS-Arm
S10
-E171A (721,2)/TM6b ; +/+
Derived from pDA721 (p89)
RH24c y w hs-flp/X= ; UAS-Arm
S10
-E171A (721,3)/Cyo ; +/+ ; +/+
Derived from pDA721 (p89)
RH25a y w hs-flp/X= ; +/+ ; UAS-Arm
S10
-D172A (722,1)/TM6b ; +/+
Derived from pDA722 (p90)
RH25b y w hs-flp/X= ; UAS-Arm
S10
-D172A (722,2)/Cyo ; +/+ ; +/+
Derived from pDA722 (p90)
RH25c y w hs-flp/X= ; UAS-Arm
S10
-D172A (722,3)/Cyo ; +/+ ; +/+
Derived from pDA722 (p90)
RH26a y w hs-flp/X= ; +/+ ; UAS-Arm
S10
-K443E (724,1)/3= ; +/+
Derived from pDA724 (p92)
RH26b y w hs-flp/X= ; +/+ ; UAS-Arm
S10
- K443E (724,2)/TM6b ; +/+
Derived from pDA724 (p92)
RH26c y w hs-flp/X= ; UAS-Arm
S10
- K443E (724,3)/Cyo ; +/+ ; +/+
Derived from pDA724 (p92)
RH27a y w hs-flp/X= ; UAS-Arm
S10
- A303W/I304W (737,1)/2= ; +/+ ; +/+
Derived from pDA737 (p91)
RH27b y w hs-flp/X= ; +/+ ; UAS-Arm
S10
- A303W/I304W (737,2)/3= ; +/+
Derived from pDA737 (p91)
RH27c y w hs-flp/X= ; +/+ ; UAS-Arm
S10
- A303W/I304W (737,5)/TM6b ; +/+
Derived from pDA737 (p91)
RH28a y w hs-flp/X= ; +/+ ; tub-myr-Arm-wt (753,2)/TM6b ; +/+
Derived from pDA753
RH28b y w hs-flp/X= ; +/+ ; tub-myr-Arm-wt (753,5)/TM6b ; +/+
Derived from pDA753
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RH28c y w hs-flp/X= ; tub-myr-Arm-wt (753,7)/Cyo ; +/+ ; +/+
Derived from pDA753
RH29a y w hs-flp/X= ; +/+ ; tub-myr-Arm-E171A (754,2)/TM6b ; +/+
Derived from pDA754
RH29b y w hs-flp/X= ; +/+ ; tub-myr-Arm-E171A (754,3)/TM6b ; +/+
Derived from pDA754
RH29c y w hs-flp/X= ; tub-myr-Arm-E171A (754,4)/Cyo ; +/+ ; +/+
Derived from pDA754
RH29d y w hs-flp/X= ; +/+ ; tub-myr-Arm-E171A (754,6)/TM6b ; +/+
Derived from pDA754
RH30 y w hs-flp/X= ; tub-myr-Arm-D172A (755,1)/Cyo ; +/+ ; +/+
Derived from pDA755
RH31a y w hs-flp/X= ; +/+ ; tub-myr-Arm-K443E (757,2)/TM6b ; +/+
Derived from pDA757
RH31b y w hs-flp/X= ; +/+ ; tub-myr-Arm-K443E (757,3)/TM6b ; +/+
Derived from pDA757
RH32a y w hs-flp/X= ; +/+ ; tub-NLS-HA-dLgs!HD1 (201,3)/TM6b ; Dp1021 [y+] spa[pol]/4=
Derived from pRH201
RH32b y w hs-flp/X= ; +/+ ; tub-NLS-HA-dLgs!HD1 (201,4)/TM6b ; Dp1021 [y+] spa[pol]/4=
Derived from pRH201
RH32c y w hs-flp/X= ; +/+ ; tub-NLS-HA-dLgs!HD1 (201,7)/TM6b ; Dp1021 [y+] spa[pol]/4=
Derived from pRH201
RH32d y w hs-flp/X= ; +/+ ; tub-NLS-HA-dLgs!HD1 (201,8)/TM6b ; Dp1021 [y+] spa[pol]/4=
Derived from pRH201
RH33a y w hs-flp/X= ; tub-Arm(myc)-Y150A (191,1)/Cyo ; +/+ ; +/+
Derived from pRH191
RH33b tub-Arm(myc)-Y150A (191,2)/FM7 ; +/+ ; +/+ ; +/+
Derived from pRH191
RH33c y w hs-flp/X= ; +/+ ; tub-Arm(myc)-Y150A (191,4)/TM6b ; +/+
Derived from pRH191
RH33d y w hs-flp/X= ; +/+ ; tub-Arm(myc)-Y150A (191,5)/TM6b ; +/+
Derived from pRH191
RH33e y w hs-flp/X= ; tub-Arm(myc)-Y150A (191,9)/Cyo ; +/+ ; +/+
Derived from pRH191
RH34a y w hs-flp/X= ; +/+ ; UAS-Arm(myc)
 S10
-Y150A (192,1)/3= ; +/+
Derived from pRH192
RH34b y w hs-flp/X= ; UAS-Arm(myc)
 S10
-Y150A (192,2)/Cyo ; +/+ ; +/+
Derived from pRH192
RH34c y w hs-flp/X= ; +/+ ; UAS-Arm(myc)
S10
-Y150A (192,3)/3= ; +/+
Derived from pRH192
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RH34d y w hs-flp/X= ; UAS-Arm(myc)
 S10
-Y150A (192,4)/Cyo ; +/+ ; +/+
Derived from pRH192
RH34e y w hs-flp/X= ; UAS-Arm(myc)
 S10
-Y150A (192,5)/Cyo ; +/+ ; +/+
Derived from pRH192
RH35 w hs-flp hs-GFP FRT18/X= ; +/+ ; tub-Arm(myc)-Y150A (191,4)/TM6b ; +/+
Derived from RH33c
RH36a tub-Arm(myc)-!C (310,1)/FM7 ; +/+ ; +/+ ; +/+
Derived from pRH310
RH36b y w hs-flp/X= ; tub-Arm(myc)-!C (310,2)/Cyo ; +/+ ; +/+
Derived from pRH310
RH36c y w hs-flp/X= ; +/+ ; tub-Arm(myc)-!C (310,3)/TM6b ; +/+
Derived from pRH310
RH36d y w hs-flp/X= ; tub-Arm(myc)-!C (310,4)/Cyo ; +/+ ; +/+
Derived from pRH310
RH36e y w hs-flp/X= ; tub-Arm(myc)-!C (310,5)/Cyo ; +/+ ; +/+
Derived from pRH310
RH36f y w hs-flp/X= ; +/+ ; tub-Arm(myc)-!C (310,6)/TM6b ; +/+
Derived from pRH310
RH37 y w hs-flp/X= ; +/+ ; tub-Arm(myc)-D172A-!C (311,1)/TM6b ; +/+
Derived from pRH311
RH38 w hs-flp hs-GFP FRT18/X= ; +/+ ; tub-Arm(myc)-!C (310,3)/TM6b ; +/+
310,3
RH39 w hs-flp hs-GFP FRT18/X= ; +/+ ; tub-Arm(myc)-D172A-!C (311,1)/TM6b ; +/+
311,1
RH40 y w hs-flp/X= ; +/+ ; tub-BCL9.2 (358,1)/TM6b ; Dp1021 [y+] spa[pol]/4=
Derived from pRH358
RH41 y w hs-flp/X= ; +/+ ; tub-BCL9.2 (395,1)/TM6b ; Dp1021 [y+] spa[pol]/4=
Derived from pRH395 with attB system
RH42 y w hs-flp/X= ; +/+ ; tub-BCL9.2 (396,1)/TM6b ; Dp1021 [y+] spa[pol]/4=
Derived from pRH396 with attB system
RH43 y w hs-flp/X= ; +/+ ; UAS-ArmS10(myc)-D172A (383,1)/TM6b ; +/+
Derived from pRH383 with attB system
RH44 y w hs-flp/X= ; +/+ ; tub-Arm(myc)-wt (387,1)/TM6b ; +/+
Derived from pRH387 with attB system
RH45 y w hs-flp/X= ; +/+ ; tub-Arm(myc)-Y150A (388,1)/TM6b ; +/+
Derived from pRH388 with attB system
RH46 Daughterless-Gal4/3=
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